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Abstract
Insertion of Genes and Operons into the Escherichia coli Genome through
Targeted Recombination.
Dennis Coss
A method whereby DNA sequences of varying size may be accurately inserted
into pre-determined locations within the Escherichia coli genome was developed.
Using a binary vector system that takes advantage of either the E. coli RecET
enzyme tandem or bacteriophage lambda’s Redαβ recombinatory proteins, this
method has the benefits of being both inducible and self-degrading, thereby
offering a level of control to the experimenter as well as alleviating any problems
that may be associated with leaving residual DNA in the bacterium.

To

demonstrate the usability of this system, two antibiotic resistance genes, as well
as the pyrroloquinoline quinone (pqq) and gluconate dehydrogenase (gadh)
operons were used as targeting molecules in three different strains of E. coli, with
three distinct genomic targets.

The location of the inserted sequences was

confirmed through a primer-specific PCR detection assay.

The combined

expression of these operons demonstrates that E. coli can be made to produce
2-ketogluconate, an organic acid previously shown to dissolve insoluble rock
phosphate, using glucose or gluconate as the sole source of carbon.
Diversification of the substrates required for the production of 2-ketogluconate
allows for the possibility of agricultural applications, while the recombinogenic
targeting system offers a variety of possible uses in the modification of DNA
molecules within the E. coli bacterium.
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Introduction
The focus of the research described within has two primary focus areas: the
isolation and expression of bacterial genes that result in mineral phosphate
solubilization and the targeted recombination of DNA fragments within the
Escherichia coli genome. The paragraphs below briefly describe the rationale
and justification behind choosing these areas as topics of research.

Gene Targeting. Over the past few years a number of methods by which DNA
is inserted or deleted from Escherichia coli in a precise and accurate manner
have been investigated, many employing either the host genes recE and recT or
the redα and redβ genes from bacteriophage lambda (6, 56, 59, 116).

The

benefit of using either of these protein tandems in E. coli is that they allow for the
induction of recombination using only a small homology sequence (116).

A

component found to be lacking from all previous approaches has been the
removal of residual genetic material required for their induction and
implementation. Having pre-existing plasmids in the bacterium can interfere with
downstream applications where additional use of plasmid DNA is required. To
address this issue, a means by which to induce the degradation of this residual
DNA has been developed. The approach employs two plasmid DNA vectors,
one possessing a low copy origin of replication and the other a high copy origin
(Figure 1).
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To the low copy plasmid (Figures 4 and 6) the following modifications had been
made: insertion of the rare-cutting intron-homing endonuclease I-SceI, driven by
the inducible arabinose promoter (PBAD), recognition sites for the I-SceI
endonuclease, the araC gene whose protein represses PBAD expression in the
absence of arabinose and either the E. coli recE or bacteriophage λ redα
endonuclease genes. To the high copy plasmid (Figures 5 and 7) the following
modifications had been made:

insertion of either the E. coli recT or

bacteriophage λ redβ annealing proteins, a targeting cassette which contains the
modification of interest flanked by sequences bearing homology to a predetermined location on the E. coli chromosome (Figure 9), the bacteriophage λ
gam gene, plus recognition sequences for the rare-cutting intron-homing
endonuclease I-SceI.

Using a high copy vector as a carrier of the

aforementioned sequences offers the benefit of having the annealing protein
over-expressed, relative to the exonuclease carried on the low copy vector,
which has been previously demonstrated to increase the efficiency with which
recombination occurs (116).

Additionally, having the targeting cassette

replicated in high numbers increases the likelihood that a recombination event
will occur.

The underlying mechanism is as follows.

Various E. coli strains will be co-

transformed with high and low copy vector tandems containing either E.coli
recET or bacteriophage λ redαβ genes.

Upon entering the bacterium, gam

expression will result in the inactivation of the RecBCD complex while RecET or
Redαβ will be independently expressed at levels favorable for recombination. In
2

order to generate the double-stranded DNA breaks required to stimulate
recombination through either of these pathways, arabinose will be added to the
growth media, thereby inducing expression of the I-SceI endonuclease which is
driven by the PBAD promoter.

Figure 1. Overall Experimental Concept. After introduction of the binary
vector system into E.coli, expression of the restriction-homing endonuclease, ISceI, is induced. The result is formation of dsDNA breaks in both of the vectors
at the I-SceI recognition sites, ultimately leading to their degradation. I-SceI sites
are located on either end of the homology arms located at the termini of the gene
to be inserted (gene X). Once the dsDNA breaks are induced at these sites
RecE or Redα resects one strand of the dsDNA at the site of the break while
RecT or Redβ binds to the remaining ssDNA. RecT or Redβ then pair to the
homologous portions of the E.coli chromosome (homology arms A and B) and
strand exchange is induced, resulting in the removal of gene Y and simultaneous
replacement by gene X.
I-SceI sites located on both plasmids will be cleaved resulting in the production of
three linear dsDNA fragments:

the linearized high-copy vector, the targeting
3

cassette and the linearized low-copy vector. Once created, either RecE or Redα
will bind to the 5’ ends and degrade the terminal portion (Figure 2). As this
occurs, either RecT or Redβ will bind to the corresponding ssDNA to prevent its
degradation and search for a homologous sequence with which to recombine.
The homology arms within the targeting cassette will direct recombination at the
targeted location within the chromosome, while the remaining linearized plasmids
will be degraded once RecBCD is again activated. This is achieved through
locating an I-SceI site near the gam gene. Once cut, either RecE or Redα will
resect the double-stranded break, effectively removing a portion of the gene and
resulting in loss of expression. Since there is no gam gene in E. coli, this DNA
fragment will not recombine with the chromosome. This same principal applies
to the remaining, linearized plasmid. The end result is therefore the insertion of
the targeting cassette at any pre-determined location on the E. coli chromosome,
along with the degradation of the plasmid vectors used to induce this process.

4

Figure 2. Mechanism of homologous recombination by RecET and Redαβ.
At the terminal end of a double-stranded DNA break either RecE or Redα (exo)
will bind and resect one of the stranded in the 5’ →3’ direction, leaving a portion
of single-stranded DNA. The portion is immediately bound by either RecT or
Redβ (bet) which protects it from degradation and also searches for a stretch of
dsDNA with homologous sequences with which to bind. Once recognized, the
double-stranded fragment is disrupted by the invading ssDNA. RecT or Redß
then promote annealing of the strands, resulting in replacement of the original
DNA fragment by the invading sequence.
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Mineral Phosphate Solubilization. In general, there are three ways by which
the availability of soluble phosphate can be increased in soil:
1. Application

of

additional

fertilizer,

manure

or

other

chemical

treatments.
2. Genetically modify plant species.
3. Genetically modify rhizobacterial species.
Additional applications of fertilizer are commonly practiced but it is a nonrenewable resource, expensive (a major detractor in underdeveloped nations)
and creates additional problems in terms of runoff into waterways (31, 95).
Genetically modifying plant species is a viable alternative and was initially
considered by our lab as the best means by which to solubilize phosphate. Other
labs have successfully modified plant genomes by the introduction of the
bacterial citrate synthase gene which facilitates the breakdown of phytate, a
loose association of soil compounds that represents twenty to fifty percent of all
available soil phosphate (54, 55, 60, 63). While this is a promising achievement,
several issues remain before this approach can be applied on a large scale; the
first of which being the localized expression of the inserted gene in the root
system. This is particularly important for crops of economic significance due the
possibility of altering a desirable phenotype. An additional problem, beyond the
scope of biological science, is the unfavorable public perception of genetically
modified crops. These problems would have to be addressed for each species of
plant modified, in addition to the variance in efficacy.

6

Genetically modifying rhizobacterial species circumvents many of these
obstacles. Making genetic modifications to bacteria is far easier than with any
multi-cellular organism and a single species could be possibly be used in
conjunction with several plant varieties. For this reason we sought to modify
bacteria to produce significant levels of the bio-acid 2-keto-D-gluconate (2KG)
which has previously been demonstrated to induce the mineral phosphate
solubilization (MPS) phenotype.

2KG is produced by the direct oxidation of

gluconic acid, a six carbon sugar acid.

To increase the availability of this

substrate the genes required for the synthesis of the cofactor pqq, which is
required for the activation of glucose dehydrogenase (GDH), were also
transferred to the E. coli chromosome. Since GDH oxidizes glucose to form
gluconic acid, the likelihood of 2KG production is increased. Also, the nature of
the substrates dictates that its production will be highly localized to the
rhizosphere, an area where soil sugar concentration is localized.

7

Literature Review
RecE and RecT physical properties:
RecE is a 120 kDa protein that acts as an ATP-independent DNA exonuclease
and is sometimes referred to as ExoVIII (49, 58). RecE has an absolute
requirement for Mg2+, with optimal activity at 20 mM. ExoVIII degrades doublestranded DNA in a 5’→ 3’ direction, yielding both 5’ mononucleotides and singlestranded DNA (33, 48, 49, 58). It displays very little activity towards singlestranded DNA and none to circular double-stranded DNA in a supercoiled, nicked
or gapped configuration (19, 48).

ExoVIII has high processivity, degrading

dsDNA on the order of 20,000 bases per binding event (39). Biochemically,
ExoVIII resembles λ exo (Redα), the product of the redα gene of bacteriophageλ.
The recE gene is located in the cryptic Rac prophage which resides in the
genomes of E. coli K-12 strains (50).

RecT is a 33 kDa protein that binds to single-stranded DNA and promotes
renaturation to complementary ssDNA strands in an ATP-independent fashion
when in the presence of RecE (23, 40). The recT gene is also located in the Rac
prophage and partially overlaps the 3’ end of the recE gene by five nucleotides,
although it is out of frame with respect to recE (23). Like RecE, the RecT protein
is also very similar in function to a bacteriophage λ gene. In case of RecT it is
the Redβ protein, which acts in concert with the Redα in the same manner as
RecE/RecT.

In fact, the RecE/RecT proteins can replace the Redα/Redβ

proteins in bacteriophage λ (40, 52, 81). The reverse is also true, but they cannot
8

interchange proteins, i.e., Redα cannot work in concert with RecT (81). This
holds true for RecE and Redβ. Interestingly, these E. coli proteins differ greatly
in size and share no sequence homology with their λ phage counterparts,
although it has been observed that the first 587 amino acids of RecE are
disposable (19).

The recE was discovered in 1970 by the Barbour lab as a gene that encoded an
ATP-independent exonuclease (13). The protein was purified by two groups and
found to have a molecular weight of 140 kDa (49, 58). Based on the size of the
protein, the gene sequence was anticipated to be an open reading frame of
approximately 4 kb. The actual size of the recE gene is 2601 base pairs (23).

The gene was first cloned from an sbcA+ strain of E. coli as a part of a 7.6 kb
HindIII insert using lambda phage as a vector (40). Recombinant phage carrying
recE were selected for by the ability to form plaques on polA and lig hosts.
Partial sequencing of recE was not done until 1989 when the Clark lab used
derivatives of plasmids which he had previously isolated in 1985 (23).

One

particular plasmid carried the nucleotide sequences for the gene racC and the Nterminal portion of the wild-type recE gene. The portion of recE in this plasmid
carried a frameshift mutation that prevented synthesis of active RecE. They
used the information from this plasmid to construct an additional series of
plasmids that carried internal and external deletions which either fused the Nterminal portion of the recE gene to the C-terminal portion of recE, or the Nterminal of the immediately upstream racC gene to the C-terminal of the recE
9

(23). This bears repeating because in addition to the sequence information they
also discovered that roughly 70% of RecE (the first 587 amino acids) were not
required to form an active enzyme (15, 57). The C-terminal portion of the gene
was not published until 1993 (23).

In wild-type E. coli the primary means of recombination is provided by the
RecBCD complex.

Subsequently, in recB recC mutant strains virtually all

recombination is abolished. Still, background recombination does occur, which
has lead to the suggestion that there is an alternate, albeit minor pathway of
recombination that is independent of RecB and RecC.

It was found that

recombination in these strains can be restored to near normal levels by an
additional mutation in sbcA locus, an indirect suppressor of the RecE and RecT
genes (13).

Although mapped to the Rac prophage inserted into the

chromosome of all E.coli K12 derivatives, the precise sequence of this DNA
element, whether it is a regulatory sequence or gene, has not been determined.

Key experiments involving RecE and RecT:
1. Isolation of the RecE protein (Exo VIII). Based on the observations that
sbcA strains maintain increased levels of an ATP-independent DNase, and that
sbcA recBC cells are still able to perform the tasks carried out by RecBC (Exo V),
the Clark lab devised a purification protocol in order to isolate the protein(s)
responsible for the continued ability to correct UV-damaged DNA (58), as well as
maintain a proficiency in recombination. Through ammonium sulfate precipitation
and ion-exchange fractionation they were able to achieve a purity of roughly 50%
10

and estimated the size of the protein by SDS-PAGE to be approximately 120
kDa.

The size of the RecE protein had been a point of discussion for some time. The
observed mass of Exo VIII by SDS-PAGE (140 kDa) is too great for the
corresponding sequence of the recE gene (96.2 kDa) (19). The Clark lab pointed
out a discrepancy between the size of the recE gene predicted by molecular
mass estimates of Exo VIII proteins and the estimated location of a Tn10
insertion which appeared to eliminate Exo VIII activity (recE101::Tn10) (23). The
Luisi-DeLuca lab subsequently showed that the insertion reduced but did not
eliminate a protein whose mobility in SDS-PAGE was the same as that of wildtype Exo VIII (52). Through later sequencing attempts it was discovered that the
estimated location of rec-101:: Tn10 is in recT (19).

Using PCR, instead of

Southern blotting (which had been used previously, the Clark lab found the exact
location of the transposable element to be between bases 3499 and 3766 of recT
(23). The Chu lab had proposed that the discrepancy was due to a series of five
alternating, for the most part, alpha-helix and beta-sheet sheet motifs in the Exo
VIII protein from amino acids 257 to 355 that was contained in an N-terminal
fragment copy of recE (recE939) (19). The observed mobility of this protein in
SDS-PAGE was 86 kDa, while the expected mass was only 65 kDa. Nested
deletions of this area yield proteins that migrate in accordance with sizes that can
be predicted by from the size of the DNA fragment.

Chou-Fasman analysis

predicts this area of recE939 to be the densest region of beta-sheets in the
protein and, on this basis, may be rendered resistant to SDS binding (19). The
11

Chu lab believed this reduction in SDS binding to be the cause of the
overestimation of size, as it would lead to a decrease in mobility on SDS-PAGE
(23). They, therefore, believe the mass of Exo VIII to be closer to 120 kDa.

Based on the sequence data for recE and recT, the Clark lab had speculated that
the observed mass of 125.9 kDa for Exo VIII may suggest a fusion of RecE and
RecT to form an active Exo VIII protein (23). This seemed reasonable since the
combined estimated mass of the two gene products (96.2 kDa and 33 kDa)
closely matches the number observed from SDS-PAGE. In order to test the
fusion protein theory they constructed a series of insertions and deletions to the
recT gene whereby observing the new estimated masses by SDS-PAGE would
indicate whether or not it was fused to the recE gene product. None of these had
an effect on the mobility of the Exo VIII protein, so the possibility of a fusion
between the recE and recT gene products as an explanation for the observed
mass of Exo VIII was discounted (23).

The RecE and RecT proteins do,

however, interact. In fact, they will co-purify through several steps, indicating that
this may indeed be another reason for the overestimation of the mass of Exo VIII.
Later sequencing of the C-terminal portion of recE showed that the Chu lab
predicted size of RecE, based on an estimation of the location of the C-terminus
closely matched its actual location, indicating that reduced migration in SDSPAGE is the likely reason for the discrepancy in mobility (19).

2. Sequencing the recE gene. The complete sequence of the recE gene is
spread over two publications. The first paper presents the sequence of the N12

terminal portion, along with a neighboring gene, racC (19). A 2.45 kb fragment
derived from one of a series of plasmids that were created in a previous
experiment had been hypothesized to contain a portion of the amino-terminal of
the RecE protein and was sequenced. The second publication would show that
the original clone, pRAC1, contained the complete sequence of the recE gene,
although it is inactive due to a frameshift mutation located after the seventh
codon of that gene (23). Although this mutation may have initially been looked
upon as misfortune, it turned out to be a blessing in disguise.

Through the

creation of a series of deletions aimed to suppress the frameshift, the Clark lab
discovered that the first 587 amino acids (nearly 70% of the N-terminal half) of
recE is not required to encode a functional Exo VIII (19). This truncated form of
the protein cuts the mass down to only 39 kDa. In addition, further sequencing
led to the discovery of the recT gene (23).

3.

Identification of the RecT protein.

The RecT protein had been

hypothesized for some time prior to its discovery (48). Some of the genetic
evidence which had suggested that there was an annealing protein that worked
in conjunction with RecE is as follows: First, the expression of recE substitutes
for two bacteriophage λ-encoded proteins required for recombination: λ exo,
encoded by the redα gene, and the redβ, protein, which is a single-stranded DNA
binding protein that can promote renaturation of DNA and stimulate RecAdependent strand exchange in vitro (15, 19, 21). Also, in phage that lack the
recombination functions encoded by λ (redα and redβ), replacement by a portion
of the E. coli-encoded Rac prophage that encodes ExoVIII allows the phage to
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grow under conditions where recombination is essential (38, 49). Second, some
recombination events in recB recC sbcA mutants do not require recA, a fact
suggesting that a second homologous pairing protein may exist and substitute for
RecA (15, 21, 23, 40, 57). This idea is consistent with the observation that λ β
protein is able to substitute for RecA under certain circumstances (49) and
suggests that the recE region may encode a λ β protein analog.

RecT was discovered by two groups in 1993 (23, 40). The RecT protein was first
purified by the Kolodner lab by using plasmids that directed the expression of
RecE or a truncated version of it (40). They noted that when high levels of
expression were attained with full-length RecE that a 33 kDa protein was coexpressed at a ratio of 10:1 (RecT: RecE).

N-terminal sequencing of RecT

revealed that the N-terminal Met is encoded by the Met codon of the recT ORF
(40). Additional information that supported the idea that recT overlapped the
recE gene was the presence of a ribosome binding site at an optimal distance
upstream of this first recT Met codon, and the protein weight was consistent with
the predicted product of the recT ORF by the Clark lab (23, 40). Biochemical
analysis of the RecT protein demonstrated that it binds specifically to ssDNA and
promotes the renaturation of complementary ssDNA, and deletion mutation
analysis shows that it is required for conjugational recombination in recB recC
strains of E. coli. The recT gene sequence was subsequently elucidated by the
Clark lab while doing sequencing work on the C-terminal of the recE gene (23).
Using the predicted nucleotide sequence from the N-terminal RecT protein they
were able to find the precise location of the corresponding nucleotides which
14

began with the final seven nucleotides of the recE gene. As alluded to earlier,
discovery of recT as a partially overlapping reading frame, in addition to the size
discrepancy of Exo VIII, raised the possibility that ExoVIII was a RecET fusion
protein. However, genetic tests showed that this was not the case (23). In
addition, the Kolodner lab have performed detailed peptide mapping experiments
with ExoVIII and RecT proteins and have shown that the two proteins have not “a
single peptide in common.” (23).

4.

ET recombination. As an alternative to using Saccharomyces cerevisiae

for in vivo recombination (22, 96), Stewart hypothesized a technique by which the
expression of RecE and RecT in E. coli could induce the exchange of DNA
fragments through homologous recombination (14).

Using PCR-generated

copies of antibiotic resistance genes flanked with homology arms of varying
length Stewart was able to show that insertion of the gene(s) into an episome
could be accomplished in a precise manner when strains of E. coli carrying the
sbcA mutation were used. SbcA normally inhibits the expression of the recE and
recT genes from the cryptic Rac prophage of E. coli K12 strains (20, 40, 77) and
is also a suppressor of recBC (13, 21). To further the usability of the technique
Stewart developed a vector, pBAD-ETγ, to express the recE and recT genes, in
addition to the Redγ (gam) gene from bacteriophage λ (14), thereby allowing this
technique to be used with the more common strains used in molecular biology
and not having to rely upon the sbcA mutation. The significance of expressing
the gam gene in addition to RecET is that it inactivates RecBCD which degrades
linear fragments of dsDNA (119).
15

In refining their technique, named ET cloning, Stewart found that over-expression
of the annealing protein, RecT, increased the overall efficiency of the technique
and that inducible expression of the exonuclease, RecE, had reduced instabilities
caused by possible background recombination events (14). Stewart also found
that the minimum length of the homology arms that was required for efficient
recombination to occur was 42 nt (14) and that nucleotide repeats at the
homology arm-DNA insert decreased this efficiency (80).

Efficiency of

recombination also plateaus when the homology arms reach a length of 100 nt
(118), and recently has proposed a possible mechanism to account for this
observation (79).

Additionally, Stewart found that using Redα and Redβ (the

functional equivalents of RecE and RecT found in bacteriophage λ) increased
recombination up to three-fold in some instances (83).

To demonstrate the versatility of ET cloning, the Stewart lab has since published
a series of papers describing experimental set-ups whereby DNA fragments of
virtually any size can be inserted or deleted with high precision from the E. coli
chromosome, linear fragments of dsDNA as well as any autonomously replicating
DNA source, such as plasmids or bacterial artificial chromosomes (17, 39, 51,
79, 80, 81, 83, 118).

5. Requirements of RecE/RecT recombination. Once the Stewart lab had
established the effectiveness of using the RecET and Redαβ recombination
pathways to make targeted insertions and deletions they conducted several
16

studies to determine the requirements of these pathways (116). As with several
of the previously conducted applications they transferred the chloramphenicol
resistance gene to make the presence or absence of recombination easily
detectable.

They first determined that both components of RecE/RecT or

Redα/Redβ were required in order for recombination to occur (81). They did this
by conducting assays where either component was absent in each system. In all
cases recombination products were absent. In addition to showing that either
pathway required the function of both the 5’-3’ exonuclease and annealing
proteins they, found that the orthologous partner is required for either pathway.
Experiments involving either heterologous pairs of RecE/RecT and Redα/Redβ
failed to yield a significant number of recombinants. To further show whether or
not the 5’-3’ exonuclease was required, conditions were set where the PCRgenerated fragment were prepared by incubation with the non-processive T7
gene 6 exonuclease or by the use of RecE to produce fragments with varying
lengths of 3’ overhang.

The resected substrates were introduced into cells

expressing components of either RecE/RecT or Redα/Redβ. Regardless of preresection, recombinants were only formed in the presence of the orthologous
pair, and efficiencies were reduced in approximate concordance with the
complete exonuclease digestion (80, 81).

Precisely defined pre-resected substrates were generated using PCR products
containing triplets of phosphothiolated nucleotides between the 50-nt homology
regions present on each end, and the chloramphenicol resistance gene.
Phosphothiolated

triplets

blocked

RecE

exonuclease

activity

in

vitro.
17

Recombination with RecE-pre-resected, phosphothiolated substrates also
required an orthologous pair and again, expression of the heterologous pairs or
any annealing protein alone did not support significant recombination (80).
Although phosphothiolated substrates inhibit RecE in vitro, equivalent efficiencies
were observed for RecE/RecT recombination in vitro regardless of whether the
substrate was unmodified, phosphothiolated, or pre-resected. This indicates that
any significant contribution by a 3’-5’ exonuclease can be discounted.
Recombination by Redα/Redβ, however, is affected by the presence of
phosphothiolated nucleotides in the substrates.

After determining the pathway requirements of RecE/RecT and demonstrating
that RecE and Redα both contribute to essential activities other than being a 5’-3’
exonuclease, the Stewart lab focused on the interaction between the RecE and
RecT proteins.

Specific physical interactions between Redα and Redβ have

been inferred from the observations that these proteins co-purify through several
steps (37, 53).

To test whether RecE and RecT interacted physically, the

Stewart lab expressed RecT as a protein-A fusion protein. Positioning protein A
at the carboxyl terminus of RecT did not impair recombination or recovery from
UV irradiation in the assays performed. Lysates from cells which expressed the
fusion proteins were passed over IgG Sepharose columns.

RecE bound to

RecT, as did other truncated forms of RecE, but Redα did not. RecE did not
interact with protein A alone, demonstrating specificity for RecT. RecE identity
was confirmed by Western analysis. The physical interaction between RecE and
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RecT was resistant to DNase I digestion. Thus RecT is able to discriminate
between RecE and Redα through physical interaction.
Pyrroloquinoline quinone
Pyrroloquinoline quinone (PQQ) is a non-covalently bound cofactor used in
several bacterial dehydrogenases and transfers redox equivalents to the
respiratory chain. The physiological electron receptors vary from ubiquinone in
the case of membrane-bound glucose dehydrogenase to a cytochrome c in the
case of methanol dehydrogenases.

It is commonly studied in three different

bacteria with the number of genes associated with its synthesis different in each:
Acinetobacter

calcoaceticus

(five),

Klebsiella

pneumoniae

(six)

and

Methylobacterium extorquens (seven). What makes isolating the pqq genes for
K. pneumoniae attractive is that, unlike the other two bacteria mentioned, they
are transcribed from a single gene cluster (73, 74).
The nucleotide sequence of the pqq operon of K. pneumoniae was determined in
1992 (74) and, as mentioned previously, consists of six genes, pqqA, B, C, D, E
and F. As opposed to M. extorquens, all of the pqq genes of K. pneumoniae are
required for synthesis.

The exact pathway of PQQ synthesis has yet to be

elucidated, but it has been determined that tyrosine and glutamate are
precursory molecules (45, 106, 107). It has been shown that the first gene in the
pqq operon in both A. calcoaceticus and K. pneumoniae is a short 24- and 23amino acid polypeptide with conserved tyrosine and glutamate residues (36).
Regarding K. pneumoniae (pqqA), they are at positions 15 and 19, respectively.
Additionally, both bacteria possess a gene whose protein demonstrates similarity
to an E. coli protease III (107), and it has been suggested that it is involved in the
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processing of the small polypeptide. For this reason it has been suggested that
this small polypeptide is the precursory molecule from which PQQ is synthesized
(36, 74). In the case of K. pneumoniae it is the pqqF gene that encodes the
speculated protease (74).

Complementation assays in M. extorquens have

suggested that this precursory polypeptide is not essential for PQQ synthesis for
this particular organism (104).

Expressing the pqq operon in E. coli serves the function of increasing the overall
substrate availability for the production of 2-ketogluconic acid. Instead of relying
solely upon the limited quantity of D-gluconate in the area immediately
surrounding the rhizosphere, the ability now exists to convert the more abundant
sugar, D-glucose into D-gluconate through the activation of GDH by the co-factor
pqq.

The membrane-bound glucose dehydrogenase (GDH) of E. coli is a quinoprotein
with PQQ as the prosthetic group (4, 5, 7, 8, 29, 84, 85). Under certain growth
conditions this enzyme makes an important contribution to energy metabolism
because it presents an alternative means to metabolize glucose (35, 44).
Predominantly, glucose is phosphorylated upon its uptake and therefore directed
to the glycolytic pathway (42). Alternatively, glucose can be oxidized to form
gluconate, whereby it is metabolized through the Entner-Doudoroff pathway to
yield glyceraldehyde-3-phosphate or pyruvate, and subsequently fed into the
glycolytic pathway. The oxidation of glucose is carried out by GDH when the
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cofactors PQQ and Mg2+ are present. Oddly, E. coli is unable to produce PQQ
(43, 44, 103).

Figure 3. Degradative Pathways of D-Gluconic Acid. Escherichia coli lacks
the ability to efficiently convert D-glucose to D-gluconate due to the lack of a
functional glucose dehydrogenase enzyme.
GDH, although transcribed constitutively, is therefore always produced in the
apoenzyme form (110). It is readily activated by the addition of PQQ and Mg2+ to
the growth media (4, 5, 35). Because the holoenzyme can be formed so readily
from the apoenzyme by addition of PQQ it is has been proposed that it is in an
almost completely folded form (27). The final step in production of the active
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holoenzyme is the binding of PQQ.

The role of apo-GDH remains unclear,

although it has been postulated that PQQ serves as a chemotactic attractant for
E. coli (85) and as an adaptive measure to environments which is where soluble
phosphate is in low concentration (2).

In most cases GDH is membrane-bound and oxidizes glucose to gluconate in the
periplasmic space, although a soluble form is also present in the periplasm (28).
The formed gluconate is subsequently taken up by various transporters and
further metabolized (87).

The reducing equivalents are donated via PQQ to

ubiquinone and then to the respiratory chain. Expression of the six pqq genes
from K. pneumoniae in E.coli results in PQQ synthesis and an active GDH (73,
74). The PQQ-binding site of GDH faces the periplasm, so the PQQ is most
likely synthesized in the cytoplasm and subsequently released into the periplasm
(111).

Several of the PQQ-producing bacteria make it in great enough

abundance to where it is often excreted into the surrounding media.

The

concentration can vary from 1µg/ml to as high as 1 mg/ml and is largely
dependant upon the availability of precursory molecules.

PQQ was discovered in 1979 in methylotropic bacteria as the cofactor for
methanol dehydrogenase (28). The cofactor was originally named methoxatin,
but was subsequently changed to pyrroloquinoline quinone.
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Gluconate Dehydrogenase
Gluconate dehydrogenase (GADH) has been characterized in Pseudomonas
aeruginosa by the Matsushita lab (69, 99).

GADH catalyzes the oxidative

conversion of D-gluconate to 2-keto-D-gluconic acid (2KG). In P. aeruginosa this
conversion occurs in the periplasmic space (3, 69, 75, 91) and the product is
detectable in the growth media (67).

The enzyme itself consists of three

subunits; a 68-kDa flavoprotein dehydrogenase subunit, a 47-kDa cytochrome c
subunit and a 24-kDa subunit of unknown function. Although sequence data for
all three of the subunits has been published (114) and a general biochemical
basis of operation has been established, no further work on the function of the
24-kDa subunit has been reported. GADH from P. aeruginosa, strain PAO1 has
been the focus of prior research in our lab making the continued use of this
organism a logical choice for this project, although the enzyme has been
characterized in several other bacterial species (71, 97).

Phosphate availability in Soil
In agriculture, phosphorous (P) is second only to nitrogen as an essential mineral
fertilizer and, as such, represents the world’s second largest agricultural
chemical. Soluble phosphorous is often the limiting mineral nutrient for biomass
production in natural ecosystems. This low availability stems mainly from two
major soil-associated factors: inorganic interaction with cations and conversion
into inorganic complexes by microbes. Even if the total P content of a given area
of soil is high, much of the available P rapidly becomes fixed to forms that are
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unavailable to the plant.

The availability of soil P is largely controlled by

biologically mediated processes such as gross mineralization and immobilization
rates (120). Changes in pH and chelation by organic acids which bind phosphate
anions also bring about phosphate in soil solution (1, 47, 109). Over 60% of all
arable soils are at a pH level above 7.0, leaving most mineral phosphate in the
form of poorly soluble calcium mineral phosphates (CaPs). Dissolution of CaPs
to Pi (H2PO4- or HPO42-) is considered essential to the global phosphorous cycle
since it is unusable to plants in an insoluble form. The concentration of available
phosphorus is generally in the micromolar range which is below that of many
micronutrients (9, 12).

Crop productivity is often limited by phosphate (Pi) availability (11). Many genes
including Pi transporters, phosphatases, RNases, and β-glucosidase are induced
during Pi starvation (89).

Low phosphate availability also alters the root

architecture of some plants such as Arabidopsis. Under these conditions some
plants will favor lateral root growth over primary root growth through an increase
in lateral root density and length (108). Pi transporters are involved in acquiring
Pi against the concentration gradient by an energy-mediated proton symport
mechanism (105).

The kinetics characterization of the Pi-uptake system by whole plants and
cultured cells indicates a high-affinity transport activity operating at low
concentrations (micromolar concentrations) and a low-affinity activity operating at
higher concentrations. Since P is in such low concentrations the high-affinity
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transporter is thought to be the primary system in plants (90) and is induced
under conditions of Pi deficiency (32).

Arbuscular mycorrhizae (AM) occur in most terrestrial plant communities and
associate with up to 80% of land plants (98). The influence of AM fungi in the
structure and productivity of agricultural and natural ecosystems has been widely
accepted (41, 98). The principle mechanism of AM-mediated P acquisition is the
growth of fungal hyphae to a region well beyond (up to 10 cm) the rhizosphere
depletion zone (root-soil interface), which results in a sequestration of P from the
bulk soil.

Mycorrhizal roots achieve higher rates of P uptake than non-

mycorrhizal roots (98), especially in P-deficient soils.

Some bacteria possess the ability to dissolve poorly soluble mineral phosphates.
This phenotype has been termed mineral phosphate solubilizing (MPS). MPS
bacteria release soluble orthophosphate (Pi) from rock phosphate ore.

MPS

bacteria using the direct oxidative pathway can release significant amounts of Pi
from calcium phosphates via this acid acidification of their extracellular
environment (10, 34, 62). It has been demonstrated that the MPS phenotype is
the result of gluconic acid and 2-ketogluconic acid production via the direct
oxidative pathway (62).

2-ketogluconic acid is one of the strongest naturally

occurring organic acids (pKa~2.6) and its production is a goal of this research
project.
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Figure 4. Targeting Cassette Diagram. A sequence that is to be inserted into
the genome is flanked by homology sequences that directs it to the desired area
of recombination. The I-SceI sites allow the targeting cassette to be excised
from the plasmid which carries it into the bacterium. The dsDNA breaks that
result from this incision also activates the RecET/Redαβ recombination process.
If a deletion is desired then the insertion sequence is simply omitted and any
sequence on the genome between the homology sequences will be deleted.
Insertion without replacement of existing genomic sequences can also be
achieved through selecting homology sites that are adjacent to each other on the
genome.
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Objectives
1. To develop a pair of tandem, inducible and site-specific recombination vector
systems for the purpose of transferring large segments of genetic material
into the Escherichia coli genome in a precise manner.

2. To confer the Mineral Phosphate Solubilization (MPS) phenotype upon
Escherichia coli through the insertion of the pyrroloquinoline quinone and
gluconate dehydrogenase operons via site-specific recombination, thereby
diversifying the substrates required in order to produce the organic acid 2ketogluconate.

The original aim of this project was to locate and sequence the genes
responsible for the MPS phenotype in Pseudomonas aeruginosa. Before the
research could be completed, the P. aeruginosa PAO1 genome sequence had
been published (109). Since publication of sequence data prompted the decision
to change the overall focus of the research.

Modifying DNA sequences in vivo has, and continues to be an area of active
research by several laboratories and factored greatly in selecting the research
presented. Not wanting to abandon the mineral phosphate solubilization efforts,
the genes responsible for this phenotype and those of the pyrroloquinoline
quinone biosynthetic pathway were incorporated into the present study through
their use as insert targets for the plasmid vectors that were developed.
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Methods

Gene Targeting, Heading A (Co-transformed with all required DNAs).
The methods described below are generalized and apply to all bacterial strains,
targeting cassettes and chromosomal targets used, as opposed to a separate
description for each combination investigated in this study.

1. Co-transforming: integrated targeting cassette.
50 µl of competent E. coli strains were co-transformed with

pBS-t-recE +

pACYC-recE/I-SceI or pBS-bet + pACYC-exo/I-SceI (approximately 0.2 µg of
each tandem plasmid) by heat shock at 42°C for 90 sec. and supplemented with
500µl of 2xYT media containing 150 mM arabinose. The tubes were then placed
in a 37°C H2O bath for 60 min., after which time 250 µl of the transformation
reaction was plated on the appropriate agar.

2. Co-transforming: linearized targeting cassette.
Conditions are identical to those above, except approximately 0.3 µg of linear
targeting vector was included in the transformation.

3. Pre-high copy transformation: integrated targeting cassette.
50 µl of competent E. coli strains were co-transformed with pBS-t-recE or pBSbet (approximately 0.2 µg of either plasmid) by heat shock at 42°C for 90 sec.
and supplemented with 500µl of 2xYT media. The tubes were then placed in a
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37°C H2O bath for 60 min., after which time 250 µl of the transformation reaction
was plated on the LB agar containing 100µg/ml ampicillin.

Colonies were

selected and grown overnight in SOB media, 100 µg/ml ampicillin at 37°C, 200
rpm. Bacteria was then made competent by the Inoue method (104) and used
for subsequent transformation by either pACYC-recE/I-SceI or pACYC-exo/I-SceI
(approximately 0.2 µg of either plasmid) and supplemented with 500µl of 2xYT
media containing 150 mM arabinose. The tubes were then placed in a 37°C H2O
bath for 60 min., after which time 250 µl of the transformation reaction was plated
on the appropriate agar.

4. Pre-high copy transformation: linear targeting cassette.
Conditions are identical to those above, except approximately 0.3 µg of linear
targeting vector was included in the transformation.

5. Pre-low copy transformation: integrated targeting cassette.
50 µl of competent E. coli strains were co-transformed with pACYC-recE/I-SceI
or pACYC-exo/I-SceI (approximately 0.2 µg of either plasmid) by heat shock at
42°C for 90 sec. and supplemented with 500µl of 2xYT media. The tubes were
then placed in a 37°C H2O bath for 60 min., after which time 250 µl of the
transformation reaction was plated on the LB agar containing 15 µg/ml
chloramphenicol. Colonies were selected and grown overnight in SOB media, 15
µg/ml chloramphenicol at 37°C, 200 rpm. Bacteria was then made competent by
the Inoue method and used for subsequent transformation by either pBS-t-recE
or pBS-bet (approximately 0.2 µg of either plasmid) and supplemented with 500µl
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of 2xYT media containing 150 mM arabinose. The tubes were then placed in a
37°C H2O bath for 60 min., after which time 250 µl of the transformation reaction
was plated on the appropriate agar.

6. Pre-low copy transformation: linear targeting cassette.
Conditions are identical to those above, except approximately 0.3 µg of linear
targeting vector was included in the transformation.

Isolating the Gluconate Dehydrogenase Operon (GADH).
P. aeruginosa PAO1 was first streaked on Luria-Bertani (LB) agar plates
containing no antibiotics overnight at 37°C.

Round, normal colonies were

selected and transferred to 3 ml of SOB media and grown overnight at 37°C with
shaking at 200 rpm. 1 ml of this culture was then used to inoculate 20 ml of
identical media and grown to mid-log phase. Genomic DNA was then isolated
using GenElute (Sigma) kits as described in the appendix and completely
digested using Kpn I. The DNA was then separated on 1% TAE-agarose at 65 V
for 2 h in order to resolve fragments in the 4- to 5 kb range. These fragments
were then ligated into Kpn I/SAP-treated pBLUESCRIPT (Stratagene) and used
to transform E. coli XL1-Blue MRF’ (Stratagene). Bacteria were then plated on
SOB agar containing 100 µg/ml ampicillin, plus 100 mM sodium gluconate to
induce enzyme activity and grown overnight at 37°C. All colonies were screened
in situ by soaking Whatmann paper with the GADH detection assay (see
appendix). Positive colonies were subsequently transferred to 1 ml LB media
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supplemented with 100 µg/ml ampicillin, plus 100 mM sodium gluconate and
grown overnight at 37°C with shaking at 200 rpm.

The bacteria was then

pelleted at 12,000 x g (1 min at room temperature), resuspended in warm 50
mM Tris-HCl, pH 7.5 containing 250 mM sodium gluconate. The bacteria was
then re-pelleted and resuspended in assay solution.

After the addition of

substrate (gluconate), positives were selected through the observation of rapid
color change.

Positives were streaked onto SOB agar containing 100 µg/ml

ampicillin and grown overnight at 37°C. Colonies were then transferred to liquid
media and grown overnight. Plasmid DNA was isolated using either procedure
listed on the appendix and digested with Kpn I and SAP. The DNA was then
separated on 1% TAE-agarose at 65 V for 2.5 h in order to resolve fragments in
the 5- to 6 kb range. DNA in the 4.5 – 5.0 kb range was extracted and treated
with Apa I. Electrophoresis was repeated in order to resolve and extract the 2.0
and 2.7 kb DNA bands. These were combined, ligated to each other, cleaned
and ligated to Kpn I-treated pBLUESCRIPT.

Repeat transformation, plasmid

isolation, Kpn I digest and electrophoresis.

The 4.7 kb band contains the

gluconate dehydrogenase operon. Label as pBS-GADH.

Isolating the pyrroloquinoline quinone operon (PQQ).
Klebsiella pneumoniae was first streaked on Luria-Bertani (LB) agar plates
containing no antibiotics overnight at 37°C.

Round, normal colonies were

selected and transferred to 3 ml of SOB media and grown overnight at 37°C with
shaking at 200 rpm. 1 ml of this culture was then used to inoculate 20 ml of
identical media and grown to mid-log phase. Genomic DNA was then isolated
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using GenElute (Sigma) kits as described in the appendix and completely
digested with Kpn I/Xba I. The DNA was then separated on 1% TAE-agarose at
65 V for 2 h in order to resolve fragments in the 8- to 9 kb range.

These

fragments were then ligated into Kpn I/Xba I, SAP-treated pBLUESCRIPT
(Stratagene) and used to transform E. coli XL1-Blue MRF’ (Stratagene). Bacteria
were then plated on S-Gal agar containing 100 µg/ml ampicillin and grown
overnight at 37°C. Transfer all white colonies to 2 ml SOB media containing 100
µg/ml ampicillin, IPTG/X-gal. Grow to mid-log phase and isolate plasmid DNA
from all positive tubes. Transform E. coli JM1109 (pts-) and plate on M9 agar
supplemented with glucose. Incubate 48 h at 37°C. All colonies present should
contain the pqq operon.

Isolate plasmid DNA and partially Bam HI digest,

followed by electrophoresis. Isolate the 6.9 kb fragment and ligate to Bam HI,
SAP-treated pACYC 184.

Amplify, isolate and completely digest with Bam HI.

The presence of three bands (4.70-, 4.25- and 2.2-kb) confirms the presence of
the pqq operon. Label as pACYC-PQQ.

Conversion of glucose to 2-ketogluconate in E. coli.
The following methodology is based on the pre-established facts that E. coli
cannot convert glucose into gluconate and the isolated DNA fragment containing
the GADH operon is not expressed in the absence of gluconate.
E. coli XL1-Blue MRF’ (Stratagene) was co-transformed with pBS-GADH and
pACYC-PQQ.

Bacteria was then plated on LB-agar containing 100 µg/ ml

ampicillin and 15µg/ml chloramphenicol to confirm the presence of both
plasmids. Colonies were transferred to 1 ml LB media containing 100 µg/ ml
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ampicillin and 15µg/ml chloramphenicol and supplemented with 100 mM
gluconate and grown to mid-log phase and pelleted at 12,000 x g (1 min at room
temperature).

Pellets were resuspended in 37°C 50 mM Tris-HCl, pH 7.5

containing 50 mM glucose, re-pelleted and resuspended in assay solution. After
the addition of substrate (glucose), positives were selected through the
observation of rapid color change. Positives were streaked onto LB agar, 100
mM gluconate, containing 100 µg/ml ampicillin and 15µg/ml chloramphenicol and
grown overnight at 37°C. Colonies were then transferred to 2 ml M9 liquid media
containing 150 mM glucose and grown to mid-log phase, pelleted at 12,000 x g
(1 min at room temperature) and resuspended in 2 ml 37°C 50 mM Tris-HCl, pH
7.5 containing 50 mM glucose. Each tube was then divided into 1 ml aliquots
and placed into separate tubes

The bacteria was then re-pelleted and

resuspended in assay solution. After the addition of substrate (glucose to one
tube and gluconate to the other), positives were selected through the observation
of rapid color change. If both tubes give a rapid color change then both pBSGADH and pACYC-PQQ are present and functioning correctly.

The reasoning behind doing the final assay to bacteria grown on minimal media
plus glucose is that the gadh operon is expressed only in the presence of
gluconate.

Since there is no gluconate in the media it has to be produced

through the action of glucose dehydrogenase (GDH) which is only active in the
presence of the co-factor PQQ. The effect of an active GDH on the assay was
not investigated. Therefore, a lone GADH assay using glucose as the substrate
may, in part, reflect the conversion of glucose to gluconate.

Performing the
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second GADH assay with gluconate as the substrate eliminates any possible
ambiguity since the presence of GADH in the cell is dependent solely upon an
active GDH.
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Results
The results are broken into four categories:


Preliminary evidence of RecET activity



Plasmid construction and DNA evidence



Biochemical assays



Targeting efficiencies

Recombination efficiencies of E. coli strains using only linear dsDNA are listed in
Table 1. Each strain was transformed with 0.3µg of DNA and plated on LB agar
containing 50µg/ml ampicillin. It is clear to see that are only two instances of
recombination. What these strains share are an sbcA mutation, a non-functional
RecBCD complex and functional RecE and RecT proteins.
Table 1. Recombination efficiencies of E. coli strains using linear dsDNA.
Colonies Efficiency(AmpR)
Strain
Genotype*
**
1.
BL21(DE3)
0
0
**
2.
JM1109
0
0
3.
JC9366
0
0
recA
4.
JC5519
0
0
recBC
5.
JC5547
0
0
recA, recBC
6.
JC8691
0
0
recBC, sbcA, recE
7.
JC8672
64
2.13x107
recA, recB, sbcA
8.
JC8679
212
7.07x107
recBC, sbcA
9.
JC9387
0
0
recBC, sbcBC
10.
JC15329
0
0
recA, recBC, sbcBC
11.
JC8111
0
0
recBC, sbcBC, recF
12.
JM109 (DE3)
0
0
recA
13.
0
0
XL1-Blue MRF'
recA
14.
JC13031
0
0
recJ
*
Complete genotypes are provided in the appendices.
**
Wild type with regards to the rec and sbc mutations considered.
A goal of this work is to temporarily transfer this expression profile to any strain of
E. coli in order to achieve targeted recombination. Upon first thought, it could be
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reasoned that using strains JC8672 and JC8679 would be a logical choice for
doing this type of work as opposed to constructing the vectors. To an extent, this
is true, but being RecBCD deficient does not lend to a stable genotype, not to
mention the lack of benefits reaped by using many of the more common cloning
and expression strains.

The

DNA

evidence

presented

within

the

results

section

consists

of

electrophoresis data for both tandem recombination vector design (Figures 2-5)
and the PCR-based detection of inserted DNA sequences (Figure 7).

The

construction of each vector is illustrated in a stepwise fashion, from plasmid
backbone to completed vector.

When constructing the vectors the genes were ordered in such a way that the
annealing protein and targeting cassette were always on the high copy plasmid,
and the exonuclease and intron-homing endonuclease were always placed on
the low copy plasmid. The primary reasoning behind this assembly is to differ
the levels of expression; the genes on the high copy plasmid need to be present
in higher levels, relative to those of the low copy plasmid. A secondary reason is
that the combined size of both plasmids lends to instability.

The GADH operon

is used as the example insert in the targeting cassette for both vector systems.
Vector maps (Figures 4A-7A) and electrophoresis gels (Figures 4B-7B) are
provided for each. The gels show the stepwise addition of DNA elements to
complete construction of each, from plasmid backbone to finished product.
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Targeting Plasmid Tandems
5. pACYC-exo/I-SceI
A.
Legend:
Plasmid
backbone
Disrupted
G

Figure 5A. The low-copy pACYC-exo/I-SceI vector. Original sequences are
denoted with yellow. The exo gene was inserted through a single restriction site
and therefore cannot be given a defined orientation on the plasmid. Expression
of the I-SceI gene is driven by the arabinose inducible PBAD promoter and
repressed by expression of the araC gene.
B.

Lanes
1. 1 kb Ladder
2. pACYC 184
3. pACYC + exo
4. pACYC + PBADISceI+araC
5. 1 kb Ladder
6. PBADI-SceI + araC
7. exo
8. I-SceI
9. 1 kb Ladder

Sizes
4.25
5.04
6.69
2.44
0.68
0.70

Figure 5B. Agarose gel displaying the construction of pACYC-exo/I-SceI vector.
The bands represented in lanes 2-4 represent the plasmid backbone, as well as
the two subsequent additions, the exo gene and the PBADI-SceI+araC DNA
fragment which was assembled prior to insertion on the pBAD22 plasmid. Lanes
6-8 represent the individual fragments of DNA which were used to assemble the
plasmid.
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Targeting Plasmid Tandems, continued.
6. pBS-bet/gam with and without the gadh operon
A.

Legend:
Plasmid
backbone
Disrupted
G

Figure 6A. The high-copy pBS-bet/gam vector. Original sequences are denoted
with yellow. All ligations are made to the Multi-Cloning Site within the lacZ gene
fragment. Not shown on the diagram are I-SceI recognition sites located at either
end of the exo gene for the purpose of linearizing the plasmid for exonuclease
degradation.
B.

Lanes
1. 1 kb Ladder
2. pBluescript
3. pBS + bet
4. pBS + bet + gam
5. gadh operon
6. pBS + bet + gam +
gadh
7. 1 kb Ladder

Sizes
2.96
3.48
5.45
5.40
10.85

Figure 6B. Stepwise construction of the pBS-bet/gam vector. Although all gene
and operons were individually substituted into the targeting cassette, only the
gadh operon is displayed as an example. Band sizes are given in kilobases to
the right of the gel.
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Targeting Plasmid Tandems, continued
7. pACYC-t-recE/I-SceI
A.

Legend:
Plasmid
backbone
Gene
i d ti

Figure 7A. The low-copy pACYC-exo/I-SceI vector. Original sequences are
denoted with yellow. The truncated recE gene was inserted through a single
restriction site and therefore cannot be given a defined orientation on the
plasmid. Expression of the I-SceI gene is driven by the arabinose inducible PBAD
promoter and repressed by expression of the araC gene.
B.

Lanes
1. 1 kb Ladder
2. pACYC 184
3. pACYC + t-recE
4. pACYC + t-recE+ PBAD
I-SceI + araC
5. 1 kb Ladder
6. PBAD I-SceI + araC
7. t-recE gene
8. I-SceI gene
9. 1 kb Ladder

Sizes
4.25
5.20
7.66
2.44
0.85
0.70

Figure 7B. Agarose gel displaying the construction of pACYC-exo/I-SceI vector.
The bands represented in lanes 2-4 represent the plasmid backbone, as well as
the two subsequent additions, the exo gene and the PBADI-SceI+araC DNA
fragment which was assembled prior to insertion on the pBAD22 plasmid. Lanes
6-8 represent the individual fragments of DNA which were used to assemble the
plasmid.

39

Targeting Plasmids, continued
8. pBS-recT/gam with and without the gadh operon
A.
Legend:
Plasmid
backbone
Disrupted
G

Figure 8A. The high-copy pBS-recT/gam vector. Original sequences are
denoted with yellow. All ligations are made to the Multi-Cloning Site within the
lacZ gene fragment. Not shown on the diagram are I-SceI recognition sites
located at either end of the exo gene for the purpose of linearizing the plasmid for
exonuclease degradation.
B.

Lanes
1. 1 kb Ladder
2. pBluescript
3. pBS + recT
4. pBS + recT + gam
5. gadh operon
pBS + recT + gam +
6.
gadh
7. 1 kb Ladder
8. gam
9. recT

Sizes
2.96
3.86
4.38
5.40
9.78
0.52
0.87

Figure 8B. Stepwise construction of the pBS-recT/gam vector. Although all
gene and operons were individually substituted into the targeting cassette, only
the gadh operon is displayed as an example.
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Detecting Recombination
The vectors used in figures 2-5 were used in tandem to induce targeted
recombination in E. coli.

As stated previously, orthologous pairs need to be

present in the bacterium in order for recombination to occur, so all possible
combinations of Rec and Red genes were not attempted. After induction of ISceI and plating, colonies were subsequently screened for the detection of
recombination with the E. coli chromosome using PCR. To do this, all primers
were selected using the following rationale: the forward primer is always specific
to the sequence immediately 5’ to the upstream homology arm and the reverse
primer is always specific to the gene(s) that are being recombined with the
chromosome (Figure 6).

Figure 9. Detecting Recombination. The forward primer is specific to an area
of the chromosome that is unchanged by recombination, while the reverse primer
is specific to the insert DNA sequence. Without proper recombination, PCR
amplification would not produce a detectable DNA fragment of known length.
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By selecting primers in this manner it is assured that differentiation between
recombinants and non-recombinants is achieved simply due to the fact that
amplification will not occur if the reverse primer cannot bind to the chromosome.
Referring to figures 7B-D, the position of the reverse primers are better
visualized. Since the sequences of both the chromosomal region and insertion
sequence are known the size of the amplification product can also be used as a
further measure of assurance that the recombination event occurred in the
proper location (Figure 7A).

Figure 10. PCR-Detected Inserts
A.

Lane
1. 1 kb Ladder
2. Kanamycin
3. Ampicillin
Conserved Prot.
4.
(gadh)
5. Gluconate DH
6. Cyto. c precursor
7. pqqB
8. pqqC
9. pqqD
10. 1 kb Ladder

Sizes
2.79
2.80
1.26
3.05
3.17
1.13
2.05
2.77

Figure 10A. PCR-detection of DNA fragments inserted into the E. coli genome
using targeted recombination. The forward primer for each band was specific to
the E. coli chromosomal sequence immediately 5’ of the targeted site and the
reverse primer specific to the particular gene(s) inserted into the chromosome.
This selection scheme ensures only amplification of genes that have been
inserted into the chromosome at proper locations on the chromosome.
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Figure 10B-D. Schematic outlay of PCR-Based Detection Assay. Genes were
detected using a forward primer specific to an unmodified portion of the E. coli
chromosome immediately upstream of the insertion site and reverse primers
specific to the particular which were inserted. Each reaction therefore produces
a band of pre-determined length (indicated for each gene in the figure above),
provided a targeted recombination event occurred. The results of these PCRdetection assays are displayed in Figure 7A.
Biochemical detection was achieved solely through colorimetric detection of the
production of 2-ketogluconate. In Table 3 each of the bacterial strains used for
recombination were tested for gluconate dehydrogenase activity and compared
to levels achieved by P. aeruginosa, the source of the gluconate dehydrogenase
operon, using dichlorophenol-indolphenol and phenazine methosulfate as an
electron acceptor/carrier. As expected, only the bacteria carrying the integrated
genes yielded a significant level of absorbance at the indicated wavelength.
Background color change is expected since dichlorophenol-indolphenol and
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phenazine methosulfate are not electron acceptors specific to gluconate
dehydrogenase. Overcoming this background level is easily achieved through
the addition of substrate to the assay solution at levels that saturate the available
active sites. Absorption at 600 nm is then converted into units of gluconate
dehydrogenase activity by dividing by 3.3 as described by Matsushita (66).

Table 2. DCPIP/PMS Detection of Gluconate Dehydrogenase Activity.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

Strain
P. aeruginosa PAO1
XL1 Blue MRF'
XL1 Blue MRF'
XL1 Blue MRF'
JM109 (DE3)
JM109 (DE3)
JM109 (DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)

Plasmid
none
pBluescript
Integrated GADH
none
pBluescript
Integrated GADH
none
pBluescript
Integrated GADH
none

A600nm/min
9.765
0.875
11.653
0.752
0.741
10.548
0.569
0.684
10.895
0.748

GADH units
2.959
0.265
3.531
0.228
0.225
3.196
0.172
0.207
3.302
0.227

One unit of GADH activity is defined as 3.3 units of absorbance at 600 nm.

Detection of pqq expression was done indirectly using the same strains of
bacteria (Table 3).

The difference here is that glucose was used as the

substrate instead of sodium gluconate.

Since pqq is a required cofactor for the

normally inactive glucose dehydrogenase in E. coli, its presence should result in
the conversion of glucose to gluconate, the substrate of GADH. This will, in turn,
be metabolized by gluconate dehydrogenase and a color change will result.
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Table 3. GADH Activity in E. coli containing both pqq and gadh Operons
and grown on M9 minimal media, plus glucose.

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

Strain
XL1 Blue MRF'
XL1 Blue MRF'
XL1 Blue MRF'
XL1 Blue MRF'
XL1 Blue MRF'
JM109 (DE3)
JM109 (DE3)
JM109 (DE3)
JM109 (DE3)
JM109 (DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)
BL21(DE3)

Plasmid
pBluescript
pBS-GADH
pACYC-PQQ
pPQQ + pGADH
none
pBluescript
pBS-GADH
pACYC-PQQ
pPQQ + pGADH
none
pBluescript
pBS-GADH
pACYC-PQQ
pPQQ + pGADH
none

A600nm/min
0.721
1.175
0.569
9.823
0.763
0.636
1.022
0.649
7.984
0.633
0.599
0.974
0.521
8.596
0.670

GADH units
0.218
0.356
0.172
2.977
0.231
0.193
0.310
0.197
2.419
0.192
0.182
0.295
0.158
2.605
0.203

One unit of GADH activity is defined as 3.3 units of absorbance at 600 nm.
The functionality pqq of the operon was measured by its ability to activate
glucose dehydrogenase, thereby converting glucose to gluconate.

To demonstrate the usability of this system, experiments were performed using
four distinct DNAs for recombination (two antibiotic resistance genes and two
operons). Recombination was carried out in three separate strains of E. coli,
whereby each of the four DNAs used for insertion were located to three separate
locations on the chromosome.

Various expression strategies were employed

with either the RecET or Redαβ recombination proteins. The table below (Table
4) represents the average recombination and transformation efficiencies for each
gene at each targeted location in each strain of E. coli. Recombination and
transformation values for each insert/target/strain combination tested are listed
individually in Appendix.
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Table 4. Recombination and transformation efficiencies of E. coli when order of
gene expression is varied
Reaction Conditions
B
3
4

A
1
ET

2
αβ

ET

αβ

ET

αβ

ET

αβ

C
5
ET

6
αβ

αβ

ET

3.65 5.31 5.27 5.64 2.57 3.42 5.96 5.64 0.27 0.44 6.01 5.76
Gene
Rec
98
98
64
73
99
99
46
53
98
99
9
12
Transform 3.76 5.02 6.07 5.76 2.86 3.80 5.65 5.40 0.27 0.44 5.79 5.71
Operon
Rec
99 100
35
48
99
99
36
47 100
99
12
17
Transform

Transform. in 107, Rec. in %

Table 4. Recombination and transformation values for the averaged gene or operon
insertion into the averaged location in the averaged E. coli strain. A, B, and C denote the
order of expression, 1-6 denotes a linearized or integrated targeting cassette and ET or
αβ denotes the recombination system employed.
Interpreting Table 4.
Table 4 represents the condensation of twelve identical tables that list the values
of each recombination event by either system (ET or αβ) into each of three
targets on the E. coli chromosome in three different stains of the bacteria. Here,
transformation and recombination values are divided between gene insertions
and operon insertions by three tiers: order of expression of the recombinatory
genes, type of targeting cassette employed (circular or pre-linearized) and means
of recombination (ET or αβ).

Recombination events falling under heading A represent the normal means by
which targeted recombination should occur. The bacteria is co-transformed with
both plasmids, with or without an integrated targeting cassette. in cases where a
pre-linearized cassette is required, a second round of transformation was
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performed. Events falling under heading B represent the cases where the high
copy plasmid, carrying the annealing protein and gam gene, is first used to
transform the bacteria, followed by a second round of transformation using the
low copy plasmid and, when applicable, the linearized targeting cassette.
Recombination events falling under heading C represent the cases where the
transformation order is opposite; the low copy plasmid, carrying the exonuclease
and intron-homing endonuclease, is used to first transform the bacteria, followed
by a second round of transformation using the high copy vector and , when
applicable, the linearized targeting cassette.

Subheadings 1-6 represent the use of either plasmids that do not contain a
targeting cassette, but instead use a pre-linearized one, or plasmids that have
the targeting cassette integrated into the high copy plasmid. All of the values that
fall under the odd-numbered subheadings use pre-linearized targeting cassettes,
while the even-numbered ones must rely upon excision via I-SceI to generate
double-stranded termini. ET and αβ simply state which binary vector system was
used, the RecET plasmids or the Redαβ plasmids. Therefore the recombination
efficiencies falling under “A. 1. ET” represent all experiments where E. coli was
co-transformed with the recE- and recT- containing plasmids, plus a prelinearized targeting cassette. “B. 4. αβ” represents all experiments where E. coli
was first transformed with the bet-containing plasmid with an integrated targeting
cassette, followed by a second round of transformation using the exo-containing
plasmid.
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Interpreting Recombination and Transformation efficiencies
It should be noted that recombination efficiency values are based on phenotypic
expression of the genes/operons that were used in the targeting cassettes and
that this tends to elevate the efficiency with which recombination occurs. Direct
screening for the phenotype, especially in the case of gene insertions
(kanamycin- and ampicillin-resistance) immediately eliminates any bacteria which
did not receive all DNAs required to induce recombination, or did not undergo
recombination at all. For this reason, all odd-numbered experiments (where a
pre-linearized targeting cassette was used) have recombination efficiencies at or
near the 100% level. All colonies must have the resistance gene inserted into
their genomes in order to maintain a sustained level of expression. While this
may not provide an accurate measure with which recombination occurs, it does
have merit when considering the accuracy with which recombination occurs.
Since PCR primers detect only recombination events that occur in the proper
location, and all colonies tested showed a positive result, it can be inferred that
this system works with high precision. This is not the case when operon insertion
is considered since survivability is not contingent upon phenotypic expression. In
these cases, colonies to be tested for recombination were screened for activity
prior to determining the efficiency of recombination. Measuring efficiency without
screening would certainly decrease this value, but this would raise questions as
to which factor causes this to occur; the absence of recombination or incomplete
transformation, since recombination cannot occur unless all DNAs are present.
When comparing transformation efficiencies of pre-linearized targeting cassettes
to that of the integrated cassettes it is clear to see that there is a significant
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increase in transformations, suggesting that incomplete transformation is indeed
occurring in cases where an integrated targeting cassette is employed. Here,
recombination need not occur in order to pass phenotypic screening. This also
offers an explanation for the observation that in cases where integrated cassettes
are employed there is a reduction in the efficiency of recombination. If the low
copy vector is not present then recombination will not occur, yet the phenotype
will be expressed in a sustained fashion since the gene(s) responsible are on the
high copy plasmid.

When considering the overall usability of the system developed, focus needs to
be given to the even-numbered conditions (2, 4 and 6) since these are the cases
where the targeting cassette is integrated into one of the vectors, namely the
high copy vector. Condition 2 falls under heading “A” and is therefore the ideal
condition for real world application since the bacteria is transformed with all DNA
required to achieve targeted recombination in one step. Average, correct gene
insertion occurred in the range of 64- to 73% of all colonies tested under these
conditions and can be considered to be a success since it minimizes the total
number of colonies required for PCR screening in order to obtain a correct
insertion.

Operon insertion seems to occur at a lower frequency, with an

observed success range of 35- to 48%. Initially, it was thought that the reduction
in success may be due, in part, in a deficiency in the pre-screening process.
Assaying for GADH expression directly on the agar plate is a finesse procedure
which gave mixed results when initially isolating the operon from P. aeruginosa,
and this could perhaps explain the drop in efficiency were it not for the data
49

obtained by using pre-linearized targeting cassettes under identical conditions.
Here, recombination is still occurring at near 100% levels, indicating that the
screening process used to select colonies for PCR verification is indeed
functioning properly. Again, this does not mean that recombination has occurred
in 100% of the colonies on these plates, but rather in 100% of the colonies that
indicated a positive result during the pre-screening. Attributing a cause to this
reduction is purely speculative, but the effect of insert size and the relative
expression levels of the exonuclease and annealing proteins are two factors that
come to mind. Nevertheless, PCR screening of ten colonies gives three to five
positives.

Condition 4 falls under heading “B” and therefore is carried out over two rounds
of transformation. Here, the high copy vector is first used to transform strains of
E.coli which can then be selected for using ampicillin. These bacteria are then
made to be chemically competent and are subsequently transformed with the low
copy vector. I-SceI is induced immediately after transformation and the bacteria
is plated, pre-screened with either the proper antibiotic or DCIP/PMS and finally
selected for PCR detection of targeted recombination. Results for gene insertion
are little lower than that of condition “A-2”, but it is reasonable to foresee the
percentage of positives approaching equality with an increase in the number of
replications performed. Operon insertions were essentially the same under these
conditions as they were under condition “A”, further underlining the possible
effect of insert size and expression ratios.
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When initially considering the recombination system, condition C is the most
attractive condition whereby this system may be employed. Here the low copy
vector is first used to transform the bacteria. Unlike the high copy plasmid, this
plasmid receives no further modification when targeting cassettes are changed.
Given the rationale that co-transformation with multiple DNAs occurs less
frequently than transformation with a single DNA, it would be beneficial to the
experimenter to first transform with the low copy vector and grow a large volume
of bacteria for downstream applications. Unfortunately, these conditions give the
lowest rates of recombination.

The problem here is believed to be with the

expression of the gam gene. Since gam is located on the high copy plasmid,
there isn’t an early expression of the Gam gene. Since I-SceI is already present,
simultaneous expression occurs after the second round of transformation and
pre-existing active RecBCD complexes are able to effectively degrade the
majority of targeting cassettes available for recombination. This problem can be
possibly circumvented by delaying the expression of the I-SceI gene. Since it is
induced by the presence of the sugar arabinose this is an achievable condition.
If this avenue were to be further explored it would be beneficial to also modify
expression of the gam gene by also making it inducible. Research has shown
that in some strains of E. coli that over-expression of Gam is toxic (112.)
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Discussion
A novel approach to targeting recombination in the E. coli genome has been
developed. Two sets of binary vectors were developed which offer the general
benefits of differential expression levels of exonuclease to annealing proteins,
transient inactivation of the RecBCD complex and targeted recombination that
have been demonstrated previously. Current approaches have focused on the
use of PCR-generated linear targeting cassettes with either RecET or Red αβ
from plasmids (24, 61, 78, 79, 80, 81, 82, 83 119), the E. coli chromosome (59,
116, 119) or replication-deficient λ prophage (112) as the driving force in
recombination. Recently, research has demonstrated that single stranded DNA
fragments can also be used for targeted recombination in the absence of the
exonuclease (RecE or Redα) and only the annealing protein (RecT or Redβ)
(113, 118). This approach may shed new light on the mechanism by which
recombination through these pathways occur.

Where this approach differs is in the means by which the linear DNA fragment is
generated.

Instead of using pre-linearized, PCR-generated DNA targeting

cassettes, here the targeting cassette is integrated within one of the vectors and
released through the inducible expression of an intron-homing endonuclease.
Doing this provides the added benefit of degrading both plasmids once
recombination has occurred.

Through the addition of recognition sites in

strategic locations on both plasmids, efficient removal of residual DNA is
achieved.
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The usability of this system has been demonstrated through the insertion of two
antibiotic-resistance genes, as well as two operons, into three distinct locations
on the E. coli chromosome.

The versatility of the system has also been

demonstrated through the use of three separate E. coli strains. As an example of
an application of this recombination system, the operons inserted resulted in the
stable expression of gluconate dehydrogenase, previously shown to confer the
MPS phenotype.

The usefulness of this phenotype was then expanded by

recombining the genes responsible for the biosynthesis of pyrroloquinoline
quinone, thereby allowing for the activation of glucose dehydrogenase and
subsequent conversion of extra-cellular glucose to gluconate, the substrate of
GADH.

The following paragraphs summarize the primary areas addressed by

this study.

Locating the inserted genes. In order to determine whether or not the genes
were inserted at the proper locations, a PCR-based detection system was
employed. All recombination events were essentially replacement of one gene
for another, or an operon, so the homology arms were designed such that the
twenty beginning and ending nucleotides of each targeted gene were left behind
when recombination occurred. Primers were designed based on these remaining
portions of each gene and used on tandem with a primer specific to the gene or
operon inserted into the chromosome. In the case of the pqq and gadh operons,
primers were designed for the detection of each of the constituent genes. Here
again, the forward primer would be based on the E. coli chromosomal gene that
was replaced and the reverse primers would correspond to each of the genes of
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the operon. In the case of the gadh operon, the first two genes had primers
based on their three prime ends, while the third primer was based on the five
prime end in order to keep the overall length of the PCR product within the range
of the particular brand of Taq polymerase employed. The pqq operon from K.
pneumoniae consists of six genes (pqqA-E) and is too long to detect all using the
five prime primer of the deleted gene, so only pqqB-D were detected using this
primer. The pqqE and pqqF genes were subsequently detected using the three
prime primer from the deleted gene (data not included).

Detection at the

nucleotide level could have been achieved through sequencing, but was not
performed.

Proper Expression. All of the genes/operons could easily be detected by the
change in phenotype that they induced.

This provided the benefit of rapid

detection of positive colonies directly from the agar plate. In the case of the
antibiotic genes, ampicillin and kanamycin resistance, selection was simply
achieved through the addition of the antibiotics to the plates.

Detection of

gluconate dehydrogenase was carried out by soaking filter paper in the
PMS/DCIP colorimetric assay solution and placing it on top of the plates once
colonies were observed. The accuracy of this method is not absolute; roughly
fifty percent of the initial positives usually turn out to be negative when restriction
analysis is used for confirmation, although repeated use of this assay sharpens
the ability to discern the positives from the background. The pyrroloquinoline
quinone operon was initially detected and subsequently isolated by using a strain
of E. coli, JM1109 that is pts- and therefore requires glucose to be converted to
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gluconate through glucose dehydrogenase. Since GDH requires PQQ, a cofactor not synthesized in E. coli, the only colonies that would grow on M9 +
glucose had to contain the pqq operon. This is a slow growing strain, and was
not used in the targeting experiments. Therefore, an indirect method of detection
was established. All E. coli strains used for the PQQ experiments were first
modified by the insertion of the gluconate dehydrogenase operon. These cells
were subsequently grown on M9 + glucose, then tested for the expression of
gluconate dehydrogenase. Since glucose is the only carbon source available,
gluconate dehydrogenase has no substrates unless PQQ is present, allowing for
the conversion of glucose to gluconate.

Removal of the targeting system. Once recombination has occurred, it is
beneficial to remove the targeting system to eliminate the potential for unwanted,
background

DNA

recombination

along

with

the

possibility

incompatibility in subsequent, downstream applications.

of

plasmid

An intron-homing

endonuclease was therefore employed to not only excise the targeting cassette
from the system but also to ensure the degradation of both plasmids.

This

system was found to be highly effective, with approximately eighty-eight percent
of all recombination-modified bacteria being found to not contain a plasmid after
being grown overnight in liquid media containing ampicillin and chloramphenicol.

Induction of the MPS phenotype.

Locating the genes responsible for the

mineral phosphate solubilization phenotype (MPS) via production of 2ketogluconate was the original aim of this project and was still utilized although
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the overall focus of the project had changed to that of a gene targeting system.
Detection of a functional gluconate dehydrogenase was achieved directly through
a colorimetric assay described by Matsushita (67) involving phenazine
methosulfate (PMS) and 2,6-dichlorophenol-indolphenol (DCIP), whereby
electrons are transferred from gluconate to DCIP causing a loss of color that is
easily detected via visible light spectrometer, as well as visually. Visual detection
of the deep blue-to-clear change was a very beneficial property of this assay
because it allows colonies to be pre-screened directly on the agar plate by
soaking Whatmann filter paper in the assay mix and placing them directly over
the colonies. False-positives are common to this procedure but it provides the
benefit of avoiding the labor-intensive transfer of all colonies present on the
plates to liquid media, after which each overnight culture is then centrifuged,
washed and resuspended in buffer for assaying spectrophotometrically in
solution.

The underlying principle for all detection assays is the speed by which positives
are detected. It was common to have to assay several dozens of colonies at
once and, in the case of MPS phenotype detection, the amount of time that the
bacteria were exposed directly affected the overall level of protonation of DCIP.
A quick means of detection was therefore necessitated for the accurate
screening of samples.

As mentioned in the methods, when detecting the

conversion of glucose to 2-ketogluconate the possibility exists where this assay
may be misleading due to the conversion of glucose to gluconate, but this has
been taken into account by assaying these bacteria separately using glucose and
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gluconate as the substrate. Since both result in a color change, it can be inferred
that glucose is indeed being converted to gluconate, then to 2-ketogluconate.
Expression of GADH is dependant upon the presence of gluconate; adding it to
the bacteria as substrate at the time of the assay does not provide enough time
for expression to occur. Therefore, pre-existing levels of gluconate exist. Given
that the bacteria are grown on defined media containing glucose as the sole
carbon source, pqq must be activating GDH.

Factors that limit the efficiency of insertion.
The efficiency of targeted DNA insertion can be affected by several factors.
Listed below are the four primary reasons:
A. Vector Design
B. Target sequence
C. Homology Arm Design
D. Transformation Efficiency

Vector Design. Four individual vectors were constructed over the course of the
project. One half are pACYC184-derived and the remaining two are pBluescript
II SK(+)-derived. In general, orientation, promoter selection and relative location
of genes within the plasmid dictate the overall functionality of the vector.

1.

pACYC184-derived vectors. Both vectors have the S. cerevisiae I-SceI

intron-homing endonuclease, driven by the PBAD promoter and regulated by the
araC gene product, inserted in identical positions. They differ only by the type of
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single-stranded exonuclease they carry:

t-recE or exo, both of which were

inserted into the tetracycline resistance gene of the vector backbone.
The PBAD-I-SceI/araC DNA fragment was initially assembled in pBAD22 and
inserted at a Cla I site that does not fall within either antibiotic resistance gene or
the p15A origin of replication. Additionally, an I-SceI recognition site was placed
immediately upstream of the PBAD promoter.

The location of this site was

selected with hopes that its proximity to the promoter sequence would delay the
cleaving of the site through competition with RNA polymerase long enough to
allow for an adequate amount of I-SceI to be transcribed. The positional effects
of the site were not investigated to determine an optimal location of the cut site,
although residual intact pBS II SK(+)-derived plasmid was observed in some
cases.

The exo gene is a Sal I/Bam HI and is in reverse orientation with respect to the
tetracycline resistance gene, while the t-recE gene is a Sal I insert.

Both

restriction sites are in-frame with the tetracycline resistance gene so the
occurrence of fusion proteins affecting the expression of these genes is a
concern, especially so with t-recE which can be inserted in either orientation. An
additional factor is the competition between RNA polymerases that transcribe off
either the t-recE/exo promoter or the tetracycline resistance gene. However, a
reduction in the overall level of expression of either of these genes is an
acceptable, even desirable effect since the repair of double stranded DNA breaks
via RecET or Redαβ is more efficient when the annealing protein is overexpressed, relative to the exonuclease (117). However, it is not known how the
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presence of a functional gene fusion product would affect the interaction of the
exonuclease with the annealing protein.

Since recombination was observed

there it is clear to see that a functional interaction had occurred, although the
affect of inserting these genes into the tetracycline resistance gene was not
investigated.

2.

pBluescript II SK(+)-derived vectors.

Both vectors derived from

pBluescript share the bacteriophage lambda gam gene, driven by the araE
promoter and an I-SceI recognition site, flanked on either side by three stop
codons an Eco RI site, a Pst I site and a Sal I site. The stop codons were
inserted as a precautionary measure due to the proximity of the gam gene to that
of the other inserted gene, either the lambda bacteriophage bet or E. coli recT
gene. Both genes are inserted in the same orientation and are spaced by only
sixty-four nucleotides when used without an insertion cassette. The addition of
the I-SceI site increases the distance by an additional sixty-six nucleotides with
the final stop codon being forty-five nucleotides upstream of the recT/bet
promoter site. When an insertion cassette is incorporated into the plasmid, as
opposed to situations where it was introduced to the bacteria in linear, doublestranded form, any possibility of positional effects negatively affecting gene
expression is ablated.

An additional source of concern is the promoter that drives expression of the gam
gene. When expressed at high levels, the gam gene product can be cytotoxic to
some strains of E. coli (37, 53). Here, the araE promoter was selected and
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apparently does not produce deleterious levels of the gam gene, although it
should be noted that it could not be determined through a journal search if any of
the strains of E. coli employed in this study were susceptible to cytotoxic effects
from gam.

Target Sequence.

When selecting chromosomal targets for insertion some

factors to consider are the distance between sites of insertion and sequence
effects. Here, a total of three sites were selected: the gntT gene, which encodes
an inner-membrane, high-affinity gluconate transporter, the galK gene, which
when disrupted causes E. coli colonies on MacConkey agar to appear as white,
and the lac operon. The distances selected within each of these targets are as
follows: (galK, 1000 bp), (lac I, 853 bp) and (gntT, 1151 bp).

In general, Stewart et al noted that the overall complexity of the DNA source
affected the overall efficiency of targeted recombination. That is to say that it is
easier to achieve success using the E. coli chromosome as a target than it is
when targeting DNA from an exogenous source. In the case of Stewart, they
used genomic DNA from mouse embryonic stem cells and genomic DNA from
yeast and E. coli.

A significant experiment that was not performed was showing the efficiency of
insertion where a large fragment of DNA

without deleting any of the

chromosomal sequence.
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Homology Arms. Second only to the proper expression of all genes required to
induce double stranded break repair is the design of the homology arms that
direct the exogenous DNA fragment to the intended site of recombination. There
are two components of the homology arm that are of significance, the length and
nucleotide sequence.

The arm length requirement has been examined

previously (117), and the occurrence of correct recombination events was found
to have a second order parabolic relationship to the length of the arm. No correct
recombinants are observed when the length of the homology arm is below
twenty-seven nucleotides and maximal efficiency is reached when the arms are
greater than or equal to sixty nucleotides.

This is an attractive feature of

recombination via RecET and Redαβ in E. coli because it makes it a more
suitable alternative over that of RecA-dependent methods of engineering which
require homology arms in the range of one kilobase (86, 88).

Restrictions on nucleotide sequence are of particular importance due to the role it
may play in the selection of a target site. It had been noted previously that areas
with short, repeating nucleotide sequences, either at the 5’ end or internal to the
homology arm are not efficient locations for replication (117), although repeating
sequences of four or less nucleotides do not appear to have a significant effect.
In addition, the effect of terminal non-homology had to be taken into
consideration due to the use of I-SceI to excise the insertion cassettes from the
targeting vectors. I-SceI recognizes a sixteen nucleotide sequence and cuts it
symmetrically, therefore leaving eight nucleotides at the termini of each cassette
that will often have a different sequence than that of the targeted site. Although
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not inhibitory to the process of recombination, it had been noted in prior
experiments that terminal non-homology will decrease the efficiency of
recognition and recombination (64, 94, 117).

This is observed in the

“Transformation and Recombination Efficiencies under varying Transformation
Conditions” tables. All of the conditions where an independent linear targeting
cassette was used had a recombination efficiency of 100% (all of the oddnumbered conditions), whereas conditions where the targeting cassette was
integrated into one of the plasmid vectors (requiring excision) shows a lower
efficiency of recombination. The range of positives varies from fifty to ninety
percent (all of the even-numbered conditions).

It should also be noted that

conditions one through four are the most applicable, since they allow for early
expression of the gam gene, thereby inactivating the exonuclease activity of the
RecBCD complex.
Transformation and recombination efficiency. All E. coli strains were made
chemically competent using the Inoue method (46) from the same solution of
reagents to reduce the variability of transformation from strain to strain.
Determination of this efficiency differs from that of the standard means by which
this is done due to the fact that this value is directly affected by the presence or
absence of the phenotype conferred through recombination. This has to be the
case for gene insertions, since the ability to resist antibiotics is immediately
obvious by the presence or absence on plates containing the antibiotic. This
approach was therefore applied similarly to operon insertions by screening for
the phenotype prior to calculating transformation efficiency.
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This same approach was applied to calculating recombination efficiency. Cases
where linearized targeting cassettes necessitated this because expression
cannot be achieved without recombination.

Recombination values for these

experiments were therefore always in the 100% range.

In order to make

comparisons between the two, the integrated targeting cassettes had to also be
screened prior to selection.
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Future Directions
1.

Potential Improvements. It should be noted that the vectors described in

this study are still in the “design” state.

While they are functional, several

modifications can be made in order to increase the overall size and efficiency of
the system. The first of which would be the choice of promoters selected to drive
expression of the genes that cause recombination to occur. In this study the
genes on the high copy pBS plasmids (recT, bet and gam) were all driven by the
strong, constitutive promoter EM7, while the genes on the low copy pACYC
plasmids (t-recE and exo) were driven by either PTET, ParaE, Pbla or PlacZ. The ISceI gene and araC genes were also on the pACYC and were driven by the PBAD
and ParaC promoters, respectively.

The PBAD promoter allows for controlled

expression of I-SceI but t-recE and exo are expressed constitutively at a level
that is unknown relative to the recT and bet genes.

As stated previously,

recombination occurs more efficiently when the annealing protein is expressed at
a level ten times greater than the exonuclease.

It was my postulation that

placing the annealing protein on a high copy plasmid and the exonuclease on a
low copy plasmid would help to offset their expression levels, relative to one
another. This was, in fact, the primary reason for splitting the targeting system
over two vectors, as opposed to including everything on a single plasmid.
Measurement of the relative levels of expression was not explored and therefore
no assessment of expression levels can be given. Using promoters with preestablished levels of expression with regards to one another instead of relying on
plasmid copy number would therefore be an advantageous modification to the
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present system.

Additionally, regulating the expression of the exonuclease

genes would also be an improvement to the system because it would further limit
the recombinogenic window.

Insertion of the targeting cassette is presently

limited by the controlled expression of the I-SceI gene, but background events
may be occurring throughout the time at which the plasmids are introduced until
that of I-SceI expression. Replacing the current promoters with an inducible
promoter would limit recombination to a more defined time and reduce the
potential of unwanted cross-over events.

The overall outlay of the vector could be also refined in order to reduce possible
inefficiencies in transcription. Two areas of concern for the present system are
the spacing and orientation of the inserted genes with respect to each other and
the antibiotic resistance genes that are included in the plasmid backbone.

Lastly, the detection of expression and metabolites could be further quantitated
through more sophisticated genetic and biochemical approaches. Quantitative
PCR could possibly be employed by isolating mRNA from bacteria containing the
recombination genes to determine the ratio of expression.

Determining the

amounts of 2-ketogluconate and pqq could also be made accurately through the
use of either mass spectrometry or high-pressure liquid chromatography.

It would be ideal to start with a plasmid that possesses little more than an origin
of replication, an extensive poly-cloning region and a means of selection.
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2.

Potential uses of targeting system. Targeted recombination can be a

powerful tool in molecular biology because it allow for the in vivo modification of
any DNA within E. coli, not necessarily the chromosome. While replacement of
chromosomal genes with different genes or operons was the focus of this study
there is a myriad of possibilities for which this system can be employed where
either insertion or deletion can be achieved with or without the insertion of new
DNA sequences.

a.

Chromosomal Modifications.

In addition to replacement of

segments of DNA, insertions and deletions in the range spanning a single
nucleotide to several kilobases can be made in a precise manner. All that is
required is enough sequence information corresponding to the sites of
recombination; approximately fifty nucleotides for the design of each homology
arm. Regardless of the distance between them, all of the DNA between can be
deleted or replaced with a new sequence of equal, lesser or greater length.

b.

Plasmid Modifications. A secondary reason for placing all genes

required for targeted recombination on to a single plasmid is that it allows for the
modification of other plasmids in vivo. In fact, it would be a worthwhile venture to
make several copies of the plasmid with differing origins of replications in order to
make modifications to any plasmid without the concern of incompatibility.
Plasmids could then be modified in the same manner as chromosomal DNA
which was stated above. Of greater use however, would be the sub-cloning of
chromosomal DNA in vivo. This can be achieved by co-transforming bacteria
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with the recombination vector plus a linearized vector. All that is required here is
terminal sequences of the section of DNA that is of interest. Homology arms
could then be designed and attached to either end of the linearized vector. Once
co-transformed, the recombination vector could then be induced to express its
genes, resulting in the strand invasion of the plasmid into the chromosome at the
locations of homology. Not only will the chromosomal DNA be transferred to the
plasmid, but the process itself will result in a circularized plasmid.
c.

BAC/YAC modifications.

Transferring DNA from the E. coli

chromosome to plasmids in vivo is a useful technique in many labs, but many
researchers often study DNA from different, often eukaryotic, sources. The use
of bacterial artificial chromosomes (BACs) and yeast artificial chromosomes
(YACs) has greatly simplified the study of genetic material from these organisms.
Oftentimes, particular areas of interest are sought after and sub-cloned into
different vectors. This can be a delicate process due to the size of the BAC or
YAC, and also is limited to the occurrence of restriction sites. Using targeted
recombination, both of these concerns can be eliminated. Here again, E. coli
could be co-transformed with a targeting vector and a linearized vector with
homology arms at either end. The region of interest would be sub-cloned in vivo,
removing the need to isolate the BAC/YAC, restriction digest, gel separate,
ligate, transform, re-isolate and sequence/restriction digest to confirm the
correctness of the insert.

3.

Detection of gluconate and 2-ketogluconate.

Throughout this study

detection of the functionality of genes and operons was determined through the
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observation of the anticipated change in phenotype. In some instances this can
be a suitable means of detection, but in other cases it would be preferable to
have a quantitative measure of the levels of expression. This point was touched
on previously in the discussion of how to improve the efficiency of the target
system as a whole, and here again it bears repeating. In this study, several
genes were used to demonstrate the principle of the recombination system. The
antibiotic resistance genes made for simple detection due to the phenotypic
changes they induce.

A worthwhile experiment would have be to plate the

positive clones on plates of increasing antibiotic concentration to see if the
expression was similar to that of the plasmids from which they were transferred.
It should be stated that the clones were plated using antibiotic concentrations
equal to standard plating conditions. The initial goal of this study though was
conversion of gluconate to 2-ketogluconate, and a second addition of the
conversion of glucose to gluconate to increase the availability of substrate. In
both cases the operons, along with all known regulatory elements, were isolated
and transferred to plasmids for the eventual use as DNA to be inserted into the
E. coli genome. Paramount to the success of this goal is the level of expression
achieved by each of these operons once they have been transferred to the
chromosome. For this reason, quantitative measurements were necessitated,
although not carried out. Mass Spectrometry is a powerful detection technique
that was explored but not taken advantage of (18, 101). Given the status of the
laboratory, off-site location and the additional costs and time required in order to
become familiar with the necessary equipment it was decided that these
experiments could not be completed in a timely manner.
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4.

Use of gabY from Pseudomonas cepacia.

A late discovery found

during a journal search for additional information regarding the MPS phenotype
was the gabY gene, isolated from P. cepacia. As a result of the expression of
this 396-base open reading frame in E. coli grown on glucose is the production of
gluconic acid (10) and conveys the ability to solubilize hydroxyapatite.
Interestingly, when PQQ is present in the medium, the gabY gene product
interacts with it synergistically, resulting in a ten-fold enhancement of gluconic
acid production.

5.

Employing

different

intron-homing

endonucleases.

The

endonuclease used in all of the experiments was the I-SceI universal coding
sequence which has a sixteen nucleotide recognition sequence that is cut in the
center of the sequence. It had been originally intended to use a different intronhoming endonuclease to conduct the excision of the targeting cassette, I-TevI,
which is found in T-even bacteriophage which recognizes a larger, twenty-five
nucleotide sequence that is not cut in the center of the sequence. The cut site is
such that it leaves less of an overhang which provides the possible benefit of
greater pairing of the homology arm to its targeted sequence.

The larger

recognition sequence would also seem to be beneficial in terms of the frequency
of cut sites throughout the E. coli genome. In reality, a wild-type form of the ITevI gene product appears to have enough recognition sites throughout the
genome to be deleterious to E. coli (16). A mutated form of the gene exists that
allows for a reduction of functionality to the point where it can be safely
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expressed in E. coli (26). I had sought a copy of this mutated form early in the
development of the project and had, in fact, a lengthy correspondence with the
research group that made the mutation, but in these attempts were in vain.
Ironically, this mutation could now be made fairly easily using the targeting
system that it was intended to be used with. Nevertheless, several other intronhoming endonucleases have been, and continue to be discovered and could be
potentially used in place of I-SceI.

An ideal endonuclease would be highly

specific, not recognize the host genome and cut its recognition sequence in an
asymmetrical manner, such that the portion of the remaining recognition
sequence that is attached to the homology arm is minimized.

This would

undoubtedly result in an increase in the overall efficiency of the system.
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Appendix A: Gene Sequences
*

All sequences obtained from the National Center for Biotechnology Information
website: http://www.ncbi.nlm.nih.gov/entrez/

1. GADH – Conserved Hypothetical Protein*
ATGCCCGATGACAAGGCCGTCAACGGCCGCCGCGACTTCCTGCGCAAGACCCTGACCGTGATCCCGGCGGT
GACCCTGGCCGGCTATGGCGTCGGCCATGCCATGCAGACGCCCGCCGCCGAGCAGGACAAACCCCGCGAAC
GCTACCAGCCTCGCTTCTTCACCAACACCGAATGGGCTTTCGTCAACGCCGCGGTGGCGCGACTGATCCCC
AGCGACGACAACGGCCCCGGCGCCATCGAGGCCGGGGTGCCGGAGTTCATCGACCGACAGATGGAAACCCC
CTACGGGCACGGCGCACTCTGGTACATGCAGGGGCCGTTCGTCACCGACGCCGCGCCGGAGTTCGGCCATC
AGTTGAAGCTGGTGCCACGCGACATCTACCGGGTCGGCATCGCCGCCCTGGAACGCTGGAGCAAGGCCAAC
AGGGCAAGCCGTTCGCCGAGCTGGAGCCGTCGGCGCAGGACGACATCCTGCAACGCCTGGAAGCCGGCCAG
ATCGACCTGCAGGACCTGCCGGCCAAGCTGCTCTTCGGCCAGTTGCTGCAAAACACCCACGAAGGCTTCTT
CTCCGATCCGCAGCACGGCGGCAATCGCGGCCTGGTGGGCTGGAAGCTGGTCGGTTTCCCCGGCGCCCGCG
CCGACTTCATGGACTGGGCCGACCGCGGCGAGAAGTATCCCTTCCCGCCGGTGGCGATTTCCGGCGAGAGG
GGTTGA

2. GADH – Gluconate Dehydrogenase*
ATGGCGACGACACTCAAACCGGTGGACGCGGTGGTGGTCGGCTTCGGCTGGACCGGAGCGATCCTGGCCAA
GGAGCTGACCGAGGCCGGGCTCAACGTGGTGGCGCTGGAGCGCGGCGAGAACCGCGATACCTATCCCGACG
GTGCCTACCCCAACACCCTCGACGAGCTGACCTACAACACCCGCGGCAAGCTGTTCCAGAATCTCTCCAAG
AGCACCGTGAGCATCCGCCACGGGATCAACGATACCGCGCTGCCCTACCGCCAGCTCTCCGCCTTCCTTCC
CGGCGACGGCGTCGGTGGCGCCGGCCTGCACTGGTCCGGCGTGCATTTCCGGATCATGCCCGAGGAACTGC
GCTTGCGCAGTCACTACGAGGAACGCTACGGCAAGAAATTCATCCCCGAAGGCATGACCATCCAGGACTAC
GGGGTCAGCTACGAGGAGCTGGAACCGCACTTCGATTTCGCCGAGAAGGTCTTCGGCACCTCCGGCACCGC
GCATACGGTCAAGGGCCAGGTGGTCGGCAAGGGCAATCCGTTCGCCGCCGACCGCTCGGACGACTTCCCGC
TGCCGGCACTGCGCCAGGTGTACTCCGCGCAACTGTTCCGCAAGGCCGCCGAGGAACTCGGCCTGCACCCC
TACGACCTGCCGGCGGCCAACGCTTCGGGGCCCTGGACCAACCCCTACGGGGTGCAGATGGGGCCGTGCAA
CTTCTGCGGCTTCTGCAGCGGCTACGCCTGCTACATGTATTCCAAGGCCTCGCCGAACCTGAACATCCTGC
CGGCGCTGCGCCAGACCCCGCTGTTCGAACTGCGCGCCAACTGCAACGTGCTCAAGGTCAACCTCGACAGC
GACGGCAGGCAAGCCACCGGCGTGACCTACGTCGACGCCCAGGGGCGCGAGATCGTGCAGCCGGCGAAGCT
GGTGATCATCAGTGCCTTCCAGTTCCACAACGTACGCCTGCTGCTGCTCTCCGGCATCGGCAAGCCCTATG
ACCCGCGTACCGGCGAGGGCGTGGTGGGGAAGAACTTCGCCTACCAGAACATGGCCACCATCAAGGCGTTC
TTCGACAAGGACGTGCATACCAACCCCTTCGTCGGCACCGGCGGCGGCGGCGTGGCGGTGGACGACTTCAA
CGCCGACAACTTCGACCACGGACCGCTGGGCTTCGTCGGCGGCTCGCCGATGTGGGTCAACCAGGCCGGCT
CCAAGCCGATCGGCGGCCTCGCCGTGCCGCCCGGCACGCCGAGCTGGGGCAGCGGCTGGAAACAGGCGGTC
AAGGACGCCTACACGCACACCGTGTCGATGGACGCCCACGGCAGCAACATGACCTACCGCGACAACTACCT
CGACCTCGACCCGACCTACAAGGACGCCTACGGCCAGCCACTGCTGCGCATGACCTTCGACTGGAAGGACA
ACGAGATCCGCATGAGCCGCTACGTCACCGAGCACATGCGCAAGATCGCCGAAGCGATGAACCCGAAGGCC
ATCTCGGTGAGCGTCAAGAACTTCGGCGACCACTTCAATACACGGGTCTACCAGACCACCCACCTGCTCGG
CGGGGCGATCATGGGCAGCGATCCGAAGACCAGTGTGCTCAACCGCTACCTGCAGAGCTGGGACGTGCACA
ACGTCTTCGTCATGGGCGCCTCGGCCTTCCCCCAGGGCACCGGCTACAACCCCACTGGGCTGGTGGCGGCG
CTGGCCTACTGGTCGGCCAAGGCGATCCGCGAGCAATACCTGAAGAACCCCGGTCCGCTGGTGCAGGCATG
A

3. GADH – Cytochrome C Precursor*
ATGAAACCGACAGCCTTCCTCGCCCTCTCCGCCCTCGCCTGCGGCATCGCCCAGGCCGCCGCAGCGCCGGA
CCCGGCCCTGGTCAGGCAGGGTGAATACCTGGCCCGCGCCGGCGATTGCGTGGCCTGCCACACCGCCAGGG
ACGGCAAGCCGTTCGCCGGGGGCCTGCCGATGGAAACGCCGATCGGCGCGGTGTACTCGACCAACATCACC
CCGGACCGCAAGACCGGCATCGGCGACTACAGCTTCGAGGACTTCGACCGTGCCGTGCGCCACGGCGTGGC
CAGATCCGGCGACACGCTCTACCCGGCGATGCCCTACCCGTCCTACGCGCGAGTCAGCGAAGCGGACATGC
GCGCCCTCTACGCCTACTTCATGCATGGCGTGGAGCCGGTGGAGCAGCCCAACAAGGCCAGCGACATCCCC
TGGCCGCTGTCGATGCGCTGGCCGCTGGCATTCTGGCGCTGGACCTTCGCTCCCGAGGTGAAGGACTTCCA
GGCCGCCGCCGGGCAGGACCCGGTGCTGGCGCGCGGCGCCTACCTGGTCGAAGGCCTTGGCCACTGTGGCG

88

CCTGCCATACCCCGCGTGGGCTGGGCATGCAGGAGAAGGCCCTGGCGGCGAGCGATGGCGCGGCCTACCTG
TCCGGCAGCGCGCCGCTGGAGAACTGGATCGCCAAGAGCCTGCGCGGCGACCACCGGACCGGACTGGGCAG
CTGGAGCGAAGCCGACCTGGTCAGCTTCCTGCGTACCGGCCGCAGCGAGCGCAGCGCGGTGTTCGGCGGCA
TGTCCGACGTGGTGGTGCACAGCATGCAGTACATGACCGACGCCGACCTCACCGCCATCGCCCGCTACCTC
AAGTCGCTGCCGCCGGCGGACCCCGCCGACCAGCCGCACGTCTACGACGAGAGCGTGGCCCAGGCACTGTT
CCACGGCGATGACAGCAAGACCGGCGCGGCGCTCTACGTCGACAACTGCGGGGCCTGCCACCGCACCGACG
GCAAGGGCTATGCGCGGGTCTTCCCGGCCCTGGCCGGCAACCCGGTAGTGACCGGCAGCGACCCGACCTCC
CTGGTGCACATCGTGCTCAAGGGCGGCACCCTGCCGGCCACCCACCAGGCACCGTCGAGCTTCACCATGCC
GCCGTTCGGCTGGCGGATGAACGACCAGGAGATCGCCGACGTGGTCAACTTCATCCGCACCAGCTGGGGCA
ACCAGGCGCCAAGCGTCAGCGTCGACGAGGTCAGGCGCCTGCGCAAGGACACCGGCGCGGCGGGTGGGCGA
CATTCCGCCGCCGGGATCGGCCGCGGCGGATCGCGGCTGA

4. PQQ-A*
ATGTGGAAGAAACCTGCTTTTATCGATTTACGTCTCGGTCTGGAAGTGACGCTGTACATTTCTAACCGTTA
A

5. PQQ-B*
ATGTTCATTAAAGTCCTCGGTTCCGCCGCCGGCGGCGGTTTCCCGCAATGGAACTGCAACTGCGCCAACTG
TCAGGGTCTGCGCGATGGCACCATTCAGGCTGCCCCCCGCACCCAGTCGTCAATTATCGTCAGCGACAACG
GTAAAGAGTGGGTGCTGTGCAACGCCTCGCCGGATATCAGCCAGCAGATTGCCCATACCCCCGAGTTAAAT
AAAGCCGGCGTACTGCGCGGAACGCATATCGGCGGCATTATTCTCACCGACAGCCAGATCGACCACACCAC
CGGGTTGCTGAGCCTGCGGGAAGGCTGCCCACATCAGGTCTGGTGCACCCCGGAGGTTCATGAGGATCTCT
CCACCGGCTTCCCGGTGTTTACCATGCTGCGGCACTGGAACGGCGGCCTGGTGCATCATCCCATCGCTCCG
CAGCAGCCTTTTACCGTTGACGCCTGTCCTGATTTGCAGTTTACCGCGGTGCCTATCGCCAGCAACGCGCC
GCCCTATTCGCCGTATCGCGACCGGCCGCTGCCGGGTCATAACGTGGCGCTGTTTATCGAAAACCGCCGCA
ACGGGCAGACGCTGTTCTATGCCCCGGGGCTGGGTGAGCCGGATGAAACCCTTCTGCCCTGGCTGCAAAAA
GCGGACTGTCTGCTGATCGATGGCACCGTCTGGCAGGATGATGAGCTGCAGGCCGCCGGCGTCGGGCGCAA
TACCGGCCGCGATATGGGCCACCTGGCGCTCGGCGACGAGCACGGGATGATGGCCCTGCTGGCCTCTCTGC
CGGCAAAACGCAAAATTCTCATTCATATTAATAACACCAACCCGATCCTTAACAAGCAGTCTCCCCAGCGC
CAGGCGCTAACGCAACAGGGGATCGAAGTGAGCTGGGACGGGATGGCAATCACCCTTCAGGATACCGCATG
CTGA

6. PQQ-C*
ATGCTGATCACTGACACGCTGTCGCCGCAGGCCTTTGAAGAGGCTCTGCGGGCTAAAGGCGCCTTCTACCA
TATTCACCACCCTTACCACATCGCCATGCATAACGGCGACGCGACCCGCAAGCAAATTCAGGGTTGGGTGG
CGAACCGGTTTTATTACCAGACCACTATTCCGCTGAAAGACGCGGCGATTATGGCCAACTGCCCGGATGCG
CAGACCCGGCGCAAATGGGTGCAGCGGATCCTCGACCACGACGGCAGCCACGGCGAGGACGGCGGGATTGA
AGCCTGGCTGCGGCTGGGGGAAGCGGTCGGTTTGAGCCGCGACGATCTGCTCAGCGAGCGTCACGTGCTGC
CCGGCGTGCGCTTCGCAGTGGATGCCTATCTCAATTTCGCTCGTCGCGCCTGCTGGCAGGAGGCGGCCTGC
AGCTCCCTGACCGAGCTGTTCGCCCCGCAGATCCATCAGTCGCGCCTCGACAGCTGGCCGCAGCACTATCC
ATGGATCAAAGAGGAAGGCTACTTTTACTTCCGCAGTCGTCTGAGCCAGGCTAACCGCGACGTTGAGCATG
GTCTGGCGCTGGCGAAGGCCTACTGCGACAGCGCTGAAAAACAGAACCGGATGCTGGAGATCCTGCAGTTT
AAGCTCGACATTCTGTGGTCGATGCTCGATGCCATGACCATGGCCTATGCCCTGCAGCGCCCGCCCTATCA
CACGGTCACCGACAAGGCGGCCTGGCACACGACCCGACTGGTGTAA

7. PQQ-D*
ATGCAGAAAACGTCCATCGTTGCCTTTCGTCGCGGCTACCGACTGCAGTGGGAAGCCGCCCAGGAGAGCCA
TGTGATCCTCTATCCGGAGGGTATGGCCAAACTCAATGAGACCGCCGCGGCGATCCTAGAGCTGGTCGATG
GCCGGCGCGACGTCGCGGCGATTATCGCCATGCTTAATGAACGTTTCCCGGAAGCCGGCGGCGTCGATGAC
GACGTCATCGAGTTCCTGCAGATCGCCTGTCAACAGAAGTGGATCACCTGCCGTGAGCCAGAGTAA

8. PQQ-E*
GTGAGCCAGAGTAAACCCACCGTCAATCCGCCACTGTGGCTGCTGGCGGAGCTGACCTACCGCTGCCCGCT
GCAGTGTCCCTACTGTTCCAATCCGCTGGACTTCGCCCGGCAGGATAAGGAGCTGACCACCGAACAATGGA
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TCGAGGTCTTTCGCCAGGCGCGGGCGATGGGCAGCGTTCAGCTGGGCTTTTCCGGCGGCGAGCCGCTGACC
CGTAAAGATCTGCCGGAGCTGATCCGCGCCGCGCGCGACCTCGGGTTCTATACCAACCTGATCACCTCCGG
GATAGGGCTGACGGAGAGCAAACTGGACGCCTTCAGCGAGGCCGGGCTGGACCATATCCAGATTAGCTTCC
AGGCCAGCGATGAAGTGCTCAACGCCGCGCTGGCCGGCAACAAAAAAGCCTTCCAGCAGAAGCTGGCCATG
GCCAAAGCAGTGAAAGCGCGCGACTACCCGATGGTGCTCAACTTCGTTCTCCATCGGCACAACATCGACCA
GCTCGATAAAATTATCGAGCTGTGCATTGAGCTGGAAGCCGATGACGTTGAGCTGGCCACCTGCCAGTTCT
ACGGTTGGGCGTTTCTTAATCGCGAAGGGCTGCTGCCGACCCGGGAACAGATCGCCCGCGCCGAGCAGGTG
GTCGCTGACTACCGGCAGAAAATGGCCGCCAGCGGCAACCTCACCAACCTGCTGTTCGTCACCCCGGACTA
TTACGAAGAGCGGCCGAAAGGCTGCATGGGCGGCTGGGGATCGATTTTCCTCAGCGTTACCCCGGAAGGCA
CCGCCCTGCCTTGCCACAGCGCGCGCCAGCTGCCGGTGGCGTTTCCGTCGGTGCTGGAGCAGAGTCTGGAA
TCGATCTGGTATGACTCATTCGGCTTCAATCGCTACCGCGGGTATGACTGGATGCCGGAGCCGTGCCGCTC
CTGTGATGAAAAAGAGAAGGACTTCGGCGGCTGTCGCTGCCAGGCCTTTATGCTGACCGGCAGCGCCGATA
ACGCCGACCCGGTGTGCAGCAAATCTCCGCATCATCACAAAATCCTCGAGGCCCGGCGCGAAGCGGCCTGC
AGCGACATAAAAGTCAGCCAGCTGCAGTTCCGCAACCGTACCCGCTCGCAGCTGATCTACCAAACCCGGGA
CCTGTAA

9. PQQ-F*
ATGACGCTGGCGACCCGCACCGTCACTTTGCCGGGCGGCCTGCAGGCCACCCTGGTCCATCAGCCGCAGGC
GGATCGCGCGGCTGCCCTGGCGCGGGTCGCCGCCGGCAGCCACCACGAACCGTCGCGCTTCCCTGGGCTGG
CGCACCTGCTGGAACACCTGCTGTTTTACGGCGGAGAGCGCTACCAGGATGATGACCGACTGATGGGCTGG
GTGCAGCGCCAGGGCGGAAGCGTGAATGCCACCACCCTGGCTCGCCATAGCGCGTTCTTTTTCGAGGTTGC
CGCCGATGCTCTGGCTGATGGTGTCGCGCGTCTACAGGAGATGCTGCAGGCCCCGCTGCTGCTCAGGGAAG
ATATTCAGCGCGAAGTGGCGGTGATTGACGCCGAGTACCGCCTGATCCAGCAGCATGAGCCATCGCGCCGG
GAAGCCGCGGTGCGCCACGCCGCCAGCGCGCCCGCGGCGTTTCGCCGCTTTCAGGTAGGCAGCGCCGACGC
GCTGGCGGGCGATCTCGCTGCGCTGCAGGCCGCCTTAGGCGATTTTCACCGCACCCATTACGTCGCCCGGC
GAATGCAGCTCTGGCTGCAGGGGCCGCAGTCGCTGGAGGCGCTCGGCGAGCTGGCGGCCCGTTTCGCCGCC
GGGCTTGCCGCAGGCGAGGCTCCGCCGCCGGCGCCGCCGCTGCGCCTGGGCGAGTTCACTGCACTGCAGCT
GGCGGTCTCCAGCCAGCCCGCGCTGTGGCGCTGCCCGCTGATCGCTTTAAGTGACAACGTCACGTTACTGC
GCGAGTTTTTGCTGGATGAAGCCCCCGGCAGCCTGATGGCCGGCCTGCGCCAGCGCCGGCTGGCCGGGGAT
GTGGCGCTGAACTGGCTGTATCAGGATCGGCACCTCGGCTGGCTGGCGCTGGTCTTCGCCAGCGACCGGCC
GGAAGAGGTCGACCGGCAGATAACCCACTGGCTGCAGGCGCTACAGCAAACGACGCCTGAGCAGCAGCAAC
ACTACTATCAGCTATCCCGCCGCCGCTTTCAGGCGCTGTCGCCTCTCGATCAGCTGCGCCAGCGGGCATTC
GGCTTTGCCCCCGGCGCGCCGCCCGCCGGGTTCGCCGATTTTTGCGCCGCCCTGCAGGTCGCCCCGTCAGT
CAGCCTGGCCTGTCAGACCGTTTCCCCAGGGGAGCCTGTTGCCACCCAGGGCTTTAGCCTGCCGCTTAGCC
GCTGGCGCCGCCGCCCTGAGTCTGACCCGGCGCTGGCGTTCGCTTTCTATCCGCAGGCCGCTGGCGATCTC
GTTGCCAAATGCCCGGAGAAAGCCGCGCCGCTGCTCCATCTCCCGTCACCGGGAGATCCGCCGAGGCTCCT
GCTGCGACCGCCCTTCTACTGCTCGCCCGATCAGGCCGAGGGGCTGGCGCGTGGGGAACAGCTGCGCCCAC
TGCTTGCCGCCCTGCGCCATGCCGGGGGACACGGCGAGTGGCATCTGTTCGACGGCAGCTGGCAGTTGACC
CTCCAGCTGCCGGAGCCAGGCCGACGGCCGGAAGCGATCCTGCAGGCCATCCTGCGGCAGCTCGCGCTCCC
GGTCGCCTCGCTGACCCCATCGCCGGAAAGTATCGCTATCCGTCATCTCATGGCTCAACTCCCCGAACGGC
TGGGTACATCCGGGCATCAGAAAGGTTGGCTGGCGGCCCTGGCCGGCGGCAGCGCAGAAGATGCGCAGTGG
GTAGCGCGTCAGCTGAGCCTGATTACCGCCCCGGTTAATCCGCCGATGCCCGCTCCGGCACCCTGCCGCCG
CGGCGTCGAACGTCTGGTTTATCCGGGAGGCGATACGGCGCTGCTGGTCTTCATTCCGCTGCCGGATGGCG
CCTCGCTGGCGGCCCTGCGGCTGCTGGCGCAGCATTGTGAGCCGCTATTTTTCCAGCGCCTGCGGGTGGAG
CAGCAGATTGGCTATGTGGTGAGCTGCCGCTATCAGCGGGTCGCCGATCGCGACGGGCTGCTGATGGCGCT
CCAGTCCCCGGATCGCCGCGCCGGGGAATTGCTGCGCTGTGGTAAAGACTTTCTGCGCCAGCTGGCCCCCA
TGGATGAGGCGACCTTCAGACCGCTACAGCAGCGCCTGGCCGCTCAGATCCGCGCCAGCAGGCCGCCAGAG
GCGCGGGCGCTGTCCGCCCTGCGTCAGGAGTATGGATTACCAGAGCTAACGCCGCAGGCGGTTGACGCGCT
GCGCGTTGCAGAGGTGGCCGATCTGGCACGCGAAATGACCCGCCGGCGTCGCCGCTGGCAGGTGCTATTCA
CGACAGGGGATTAA

10. λ exo*
ATGACACCGGACATTATCCTGCAGCGTACCGGGATCGATGTGAGAGCTGTCGAACAGGGGGATGATGCGTG
GCACAAATTACGGCTCGGCGTCATCACCGCTTCAGAAGTTCACAACGTGATAGCAAAACCCCGCTCCGGAA
AGAAGTGGCCTGACATGAAAATGTCCTACTTCCACACCCTGCTTGCTGAGGTTTGCACCGGTGTGGCTCCG
GAAGTTAACGCTAAAGCACTGGCCTGGGGAAAACAGTACGAGAACGACGCCAGAACCCTGTTTGAATTCAC
TTCCGGCGTGAATGTTACTGAATCCCCGATCATCTATCGCGACGAAAGTATGCGTACCGCCTGCTCTCCCG
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ATGGTTTATGCAGTGACGGCAACGGCCTTGAACTGAAATGCCCGTTTACCTCCCGGGATTTCATGAAGTTC
CGGCTCGGTGGTTTCGAGGCCATAAAGTCAGCTTACATGGCCCAGGTGCAGTACAGCATGTGGGTGACGCG
AAAAAATGCCTGGTACTTTGCCAACTATGACCCGCGTATGAAGCGTGAAGGCCTGCATTATGTCGTGATTG
AGCGGGATGAAAAGTACATGGCGAGTTTTGACGAGATCGTGCCGGAGTTCATCGAAAAAATGGACGAGGCA
CTGGCTGAAATTGGTTTTGTATTTGGGGAGCAATGGCGATGA

11. λ bet*
ATGAGTACTGCACTCGCAACGCTGGCTGGGAAGCTGGCTGAACGTGTCGGCATGGATTCTGTCGACCCACA
GGAACTGATCACCACTCTTCGCCAGACGGCATTTAAAGGTGATGCCAGCGATGCGCAGTTCATCGCATTAC
TGATCGTTGCCAACCAGTACGGCCTTAATCCGTGGACGAAAGAAATTTACGCCTTTCCTGATAAGCAGAAT
GGCATCGTTCCGGTGGTGGGCGTTGATGGCTGGTCCCGCATCATCAATGAAAACCAGCAGTTTGATGGCAT
GGACTTTGAGCAGGACAATGAATCCTGTACATGCCGGATTTACCGCAAGGACCGTAATCATCCGATCTGCG
TTACCGAATGGATGGATGAATGCCGCCGCGAACCATTCAAAACTCGCGAAGGCAGAGAAATCACGGGGCCG
TGGCAGTCGCATCCCAAACGGATGTTACGTCATAAAGCCATGATTCAGTGTGCCCGTCTGGCCTTCGGATT
TGCTGGTATCTATGACAAGGATGAAGCCGAGCGCATTGTCGAAAATACTGCATACACTGCAGAACGTCAGC
CGGAACGCGACATCACTCCGGTTAACGATGAAACCATGCAGGAGATTAACACTCTGCTGATCGCCCTGGAT
AAAACATGGGATGACGACTTATTGCCGCTCTGTTCCCAGATATTTCGCCGCGACATTCGTGCATCGTCAGA
ACTGACACAGGCCGAAGCAGTAAAAGCTCTTGGATTCCTGAAACAGAAAGCCGCAGAGCAGAAGGTGGCAG
CATGA

12. λ gam*
ATGGATATTAATACTGAAACTGAGATCAAGCAAAAGCATTCACTAACCCCCTTTCCTGTTTTCCTAATCAG
CCCGGCATTTCGCGGGCGATATTTTCACAGCTATTTCAGGAGTTCAGCCATGAACGCTTATTACATTCAGG
ATCGTCTTGAGGCTCAGAGCTGGGCGCGTCACTACCAGCAGCTCGCCCGTGAAGAGAAAGAGGCAGAACTG
GCAGACGACATGGAAAAAGGCCTGCCCCAGCACCTGTTTGAATCGCTATGCATCGATCATTTGCAACGCCA
CGGGGCCAGCAAAAAATCCATTACCCGTGCGTTTGATGACGATGTTGAGTTTCAGGAGCGCATGGCAGAAC
ACATCCGGTACATGGTTGAAACCATTGCTCACCACCAGGTTGATATTGATTCAGAGGTATAA

13. recT*
ATGACTAAGCAACCACCAATCGCAAAAGCCGATCTGCAAAAAACTCAGGGAAACCGTGCACCAGCAGCAGT
TAAAAATAGCGACGTGATTAGTTTTATTAACCAGCCATCAATGAAAGAGCAACTGGCAGCAGCTCTTCCAC
GCCATATGACGGCTGAACGTATGATCCGTATCGCCACCACAGAAATTCGTAAAGTTCCGGCGTTAGGAAAC
TGTGACACTATGAGTTTTGTCAGTGCGATCGTACAGTGTTCACAGCTCGGACTTGAGCCAGGTAGCGCCCT
CGGTCATGCATATTTACTGCCTTTTGGTAATAAAAACGAAAAGAGCGGTAAAAAGAACGTTCAGCTAATCA
TTGGCTATCGCGGCATGATTGATCTGGCTCGCCGTTCTGGTCAAATCGCCAGCCTGTCAGCCCGTGTTGTC
CGTGAAGGTGACGAGTTTAGCTTCGAATTTGGCCTTGATGAAAAGTTAATACACCGCCCGGGAGAAAACGA
AGATGCCCCGGTTACCCACGTCTATGCTGTCGCAAGACTGAAAGACGGAGGTACTCAGTTTGAAGTTATGA
CGCGCAAACAGATTGAGCTGGTGCGCAGCCTGAGTAAAGCTGGTAATAACGGGCCGTGGGTAACTCACTGG
GAAGAAATGGCAAAGAAAACGGCTATTCGTCGCCTGTTCAAATATTTGCCCGTATCAATTGAGATCCAGCG
TGCAGTATCAATGGATGAAAAGGAACCACTGACAATCGATCCTGCAGATTCCTCTGTATTAACCGGGGAAT
ACAGTGTAATCGATAATTCAGAGGAATAA

14. t-recE*
ATGGATCCCGTAATCGTAGAAGACATAGAGCCAGGTATTTATTACGGAATTTCGAATGAGAATTACCACGC
GGGTCCCGGTATCAGTAAGTCTCAGCTCGATGACATTGCTGATACTCCGGCACTATATTTGTGGCGTAAAA
ATGCCCCCGTGGACACCACAAAGACAAAAACGCTCGATTTAGGAACTGCTTTCCACTGCCGGGTACTTGAA
CCGGAAGAATTCAGTAACCGCTTTATCGTAGCACCTGAATTTAACCGCCGTACAAACGCCGGAAAAGAAGA
AGAGAAAGCGTTTCTGATGGAATGCGCAAGCACAGGAAAAACGGTTATCACTGCGGAAGAAGGCCGGAAAA
TTGAACTCATGTATCAAAGCGTTATGGCTTTGCCGCTGGGGCAATGGCTTGTTGAAAGCGCCGGACACGCT
GAATCATCAATTTACTGGGAAGATCCTGAAACAGGAATTTTGTGTCGGTGCCGTCCGGACAAAATTATCCC
TGAATTTCACTGGATCATGGACGTGAAAACTACGGCGGATATTCAACGATTCAAAACCGCTTATTACGACT
ACCGCTATCACGTTCAGGATGCATTCTACAGTGACGGTTATGAAGCACAGTTTGGAGTGCAGCCAACTTTC
GTTTTTCTGGTTGCCAGCACAACTATTGAATGCGGACGTTATCCGGTTGAAATTTTCATGATGGGCGAAGA
AGCAAAACTGGCAGGTCAACAGGAATATCACCGCAATCTGCGAACCCTGTCTGACTGCCTGAATACCGATG
AATGGCCAGCTATTAAGACATTATCACTGCCCCGCTGGGCTAAGGAATATGCAAATGACTAAGTCGAC
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15. I-SceI*
ATGCATCAAAAAAACCAGGTAATGAACCTGGGTCCGAACTCTAAACTGCTGAAAGAATACAAATCCCAGCT
GATCGAACTGAACATCGAACAGTTCGAAGCAGGTATCGGTCTGATCCTGGGTGATGCTTACATCCGTTCTC
GTGATGAAGGTAAAACCTACTGTATGCAGTTCGAGTGGAAAAACAAAGCATACATGGACCACGTATGTCTG
CTGTACGATCAGTGGGTACTGTCCCCGCCGCACAAAAAAGAACGTGTTAACCACCTGGGTAACCTGGTAAT
CACCTGGGGCGCCCAGACTTTCAAACACCAAGCTTTCAACAAACTGGCTAACCTGTTCATCGTTAACAACA
AAAAAACCATCCCGAACAACCTGGTTGAAAACTACCTGACCCCGATGTCTCTGGCATACTGGTTCATGGAT
GATGGTGGTAAATGGGATTACAACAAAAACTCTACCAACAAATCGATCGTACTGAACACCCAGTCTTTCAC
TTTCGAAGAAGTAGAATACCTGGTTAAGGGTCTGCGTAACAAATTCCAACTGAACTGTTACGTAAAAATCA
ACAAAAACAAACCGATCATCTACATCGATTCTATGTCTTACCTGATCTTCTACAACCTGATCAAACCGTAC
CTGATCCCGCAGATGATGTACAAACTGCCGAACACTATCTCCTCCGAAACTTTCCTGAAATAACTGCAG

16. β-lactamase *
ATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCA
CCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGG
ATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAA
GTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTA
TTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAG
AATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCTGACAACGATCGGAGGA
CCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGA
GCTGAATGAAGCCATACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCA
AACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAA
GTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGA
GCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACA
CGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAG
CATTGGTAA

17. Kanamycin Resistance*
ATGAGCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATA
TGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCGATCGATTGTATGGGAAGCCCG
ATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGTTACAGATGAGATGGTCAGA
CTAAACTGGATGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATG
GTTACTCACCACTGCGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAA
ATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCTTTTAAC
AGCGATCGCGTATTTCGTCTCGTCCAGGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTT
TGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAGCTTTTGCCATTCTCAC
CGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGT
TGTATTGATGTTGGACGAGTCGGAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGG
TGAGTTTTCTCCTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAAT
TGCAGTTTACTTTGATGCTCGATGAGTTTTTCTAA

18. EM7 Promoter*
ATTAATTAACTGTTGACAATTAATCATCGGCATAGTATATCGGCATAGTATAATACGACAAGGTGAGGAAC
TAAACCCAGGAGG

19. ParaE*

TCCATATTTATGCTGTTTCCGACCTGACACCTGCGTGAGTTGTTCACGTATTTTTTCACTATGTCTTACTC
TCTGCTGGCA

20. PlacZ*

GCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCG
GATAACAATT

21. PTetR*
92

TAATGCGGTAGTTTATCACAGTTAAATTGCTAACGCAGTCAGGCACCGTGT

22. Pbla*

TGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGT
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Appendix B: Escherichia coli strain genotypes.
E. coli Strain
BL21(DE3)

Genotype
E. coli B F– ompT hsdS(rB– mB–) dcm+ gal λ(DE3) endA

JC13031

thr-1, araC14, leuB6(Am), DE(gpt-proA)62, lacY1, tsx-33,
glnV44(AS), galK2(Oc), LAM-, Rac0, hisG4(Oc), rfbD1,
recA13, recJ153, rpsL31(strR), kdgK51, xylA5, mtl-1,
argE3(Oc), thi-1,rpsL31(strR), xylA5, mtl-1, argE3(Oc), thi-1

JC15329

thr-1, araC14, leuB6(Am), DE(gpt-proA)62, lacY1, tsx-33, qsr’0, glnV44(AS), galK2(Oc), LAM-, Rac-0, sbcB15, hisG4(Oc),
rfbD1, DE(recA-srl)306, srlR301::Tn10, recB21, recC22,
rpsL31(strR), kdgK51, xylA5, mtl-1, argE3(Oc), thi-1

JC5519

thr-1, araC14, leuB6(Am), DE(gpt-proA)62, lacY1, tsx-33, qsr’0, glnV44(AS), galK2(Oc), LAM-, Rac-0, hisG4(Oc), rfbD1,
mgl-51, recB21, recC22, rpsL31(strR), kdgK51, xylA5, mtl-1,
argE3(Oc), thi-1

JC5547

thr-1, araC14leu B6 (Am), DE(gpt-proA)62, lacY1, tsx-33,
glnV44 (AS), galK2 (Oc), LAM-,hisG4(Oc), rfbD1, mgl-51,
recA13 , recB21, recC22, rpsL31(strR), kdgK51, xylA5, mtl-1,
argE3(Oc), thi-1, rac-

JC8111

thr-1, araC14, leuB6(Am), DE(gpt-proA)62, lacY1, tsx-33, qsr’0, glnV44(AS), galK2(Oc), LAM-, Rac-0, hisG4(Oc), rfbD1,
mgl-51, recB21, recC22, rpsL31(strR), kdgK51, xylA5, mtl-1,
argE3(Oc), recF143, qrgE3(Oc), thi-1

JC8672

Leu-277(Am), lac-301, LAM-, trp9851(Oc), sbcA20 (Rac)his318, recA56, recB21, In(rrnD-rrnE)1rpsL321

JC8679

thr-1, araC14leu B6 (Am), DE(gpt-proA)62, lacY1, tsx-33,
glnV44 (AS), galK2 (Oc), LAM-, sbc23 (Rac), his-60, rel1A,
recB21, recC22, rpsL31(strR), xylA5, mtl-1, argE3 (Oc), thi-1

JC8691

thr-1 leu-6 thi-1 lacY1 galK2 ara-14 xyl-5 mtl-1 proA2 his-4
argE3 str-31 tsx-33 supE44 rec+, recB21 recC22 sbcA2,
recE159

JC9366

thr-1, araC14, leuB6(Am), DE(gpt-proA)62, lacY1, tsx-33, qsr’0, glnV44(AS), galK2(Oc), LAM-, hisG4(Oc), recA13,
rpsL31(strR), xylA5, mtl-1, argE3(Oc), thi-1

JC9387

thr-1, araC14, leuB6(Am), DE(gpt-proA)62, lacY1, tsx-33, qsr’0, glnV44(AS), galK2(Oc), LAM-, sbcB15, hisG4(Oc), rfbD1,
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DE(recA-srl)306,
srlR301::Tn10,
recB21,
rpsL31(strR), kdgK51, xylA5, mtl-1, argE3(Oc), thi-1

recC22,

JM109 (DE3)

endA1, recA1, gyrA96, thi, hsdR17 (r^- k, m^+ k), relA1,
supE44, delta (lac-proAB), [F', traD36, proAB, lacI^q Z delta
M15], lambda (DE3)

JM1109

galK2(Oc), ptsG23, ptsM8, thyA111, galP64

XL1-Blue MRF'

D(mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1
recA1 gyrA96 relA1 lac [F'proAB lacIqZDM15 Tn10 (Tetr)]
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Appendix C: PCR Primers.
1. Escherichia coli
GALK F
GALK R

GCATCATGATTCTGAAAGAAAAAACACAA
GCATCTCAGCACTGTCCTGCTCCTTGTGA

RecT F
RecT R

GCATCAACGCGTATGACTAAGCAACCACCAATC
GCATCATCTAGATTATTCCTCTGAATTATCGAT

t-RecE F
t-RecE R

GCATCAACGCGTATGGATCCCGTAATCGTAGAAGAC
GCATCAGAGCTCTTACTGATTTGCATATTCCTTAGC

gntT F
gntT R

GCATCATGCCATTAGTCATTGTTGCTATCGG
GCATCTCAAATCACCATATTCAGCAGCAGAC

Lac F
Lac R

GCATCGTGAAACCAGTAACGTTATACGATGCTG
GCATCTCACTGCCCGCTTTCCAGTCGGGAAAC

2. Bacteriophage λ
Bet F
Bet R

GCATCAACG CGTATGAGTACTGCACTCGCAACG
GCATCATCTAGATCATGCTGCCACCTTCTGCTCTGC

Exo F
Exo R

GCATCAACGCGTATGACACCGGACATTATCCT
GCATCAGGATCCTCATCGCCATTGCTCCCCAAA

Gam F
Gam R

GCATCAACGCGTATGGATATTAATACTGAAAC
GCATCAGGGCCCTTATACCTCTGAATCAATATCAACCTG

3. Homology Arms
HAS-F-Xho
HBS-R-Xho
HB-R-Xho
HA-F-XHO
HA-R-KPN
HB-F-KPN

GCATCACTCGAGTAGGGATAACAGGGTAATCTGAATTAACATTCCCAACCGCGTGGC
GCATCACTCGAGTAGGGATAACAGGGTAATGCACTTCAAACTGGCTGGTAATATAT
GCATCACTCGAGCACTTCAAACTGGCTGGTAATATATATTTAAAGCAGCCCACCAGCA
GCATCACTCGAGCTGAATTACATTCCCAACCGCGTGGCACAACAACTGGCG
GCATCAGGTACCTGTTTCCCCGCCAGTTGTTGTGCCACGCGGTTGGGAATGTAATT
GCATCAGGTACCGTTCCTGCTGGTGGGCTGCTTTAAATATATTACCAGCCAGTTG

HOMOL1F
HOMOL2F
HOMOL1R
HOMOL2R
HOMOL2SR
HOMOL1SF

GCATCACTCGAGTAGCCTTGCCCTGATCATGGGTTTTGGCGCAATGCT
GCATCAGGTACCTGACTATCGGCGAAGACCATCAAATCCTGGTCGATGCTGGAAAC
GCATCAGGTACCAGCATTTTGCCCAGCATTGCGCCAAAACCCATGATCAGGGCAAG
GCATCACTCGAGATAATGGTTTCCAGCATCGACCAGGATTTGATGGTCTCGC
GCATCACTCGAGTAGGGATAACAGGGTAATAGATAATGGTTTCCAGCATCGACCAG
GCATCACTCGAGTAGGGATAACAGGGTAATAGATAATGGTTTCCAGCATCGACCAG

HK1 F
HSK1 F
HK1 R
HK2 R

GCATCACTCGAGCAATCTCTGTTTGCCAACGCATTTGGCTACCCTGCCATT
GCATCACTCGAGTAGGGATAACAGGGTAATGCAATCTCTGTTTGCCAACGC
GCATCAGGTACCTAGCCAAATGCGTTGGCAAACAGAGATTGTGTTTTTTCT
GCATCACTCGAGGTGATGGTTTACAAACGTAAAAAGTCTCTTAATACCTGTT
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HSK2 R
HK2 F

GCATCACTCGAGTAGGGATAACAGGGTAATCAGCACTGTCCTGCTCCTTG
GCATCAGGTACCAAGAGACTTTTTACGTTTGTAAACCATCACAAGGAGCAG

HLAC F
HLAC2 R
HLACS F
HLAC2S R
HLAC R
HLAC2 F

GCATCCTCGAGGCAGAGTATGCCGGTGTCTCTTATCAGACCGTTTCCCGCGT
GCATCCTCGAGGGGAAACCTGTCGTGCCACGTGCATTAATGAATCGGCCAA
GCATCCTCGAGACTCGAGTAGGGATAACAGGGTAATGCAGAGTATGCCGGTGT
GCATCACTCGAGTAGGGATAACAGGGTAATGGGAAACCTGTCGTGCCACGTGC
GCATCGGTACCTGGTTCACCACGCGGGAAACGGTCTGATAAGAGACACCGGCA
GCATCGGTACCGGGAAACCTGTCGTGCCATTAATGAATCGGCCAACGCGCGGG

4. Promoters
EM7-F
EM7-RBam
EM7-R-Xba
EM7-R-Apa
EM7-R-Sal
EM7-R-Kpn

GCATCACGCGTATTAATTAACTGTTGACAATTAATCATCGGCATAGTATATCGGCATAG
GCATCGTCGACGTTTAGTTCCTCACCTTGTCGTATTATACTATGCCGATATACTATGCC
GCATCTCTAGAGTTTAGTTCCTCACCTTGTCGTATTATACTATGCCGATATACTATGCC
GCATCGGGCCCGTTTAGTTCCTCACCTTGTCGTATTATACTATGCCGATATACTATGCC
GCATCGTCGACGTTTAGTTCCTCACCTTGTCGTATTATACTATGCCGATATACTATGCC
GCATCGGATCCGTTTAGTTCCTCACCTTGTCGTATTATACTATGCCGATATACTATGCC

ParaE-F
ParaE-R

ACGGCTCTGCCAGCAGAGAGTAAGACATAGTGAAAAAATACGTGAACAAG

Ptet-F
Ptet-R

GGATCCTAATGCGGTAGTTTATCACAGTTAAATTGCTAA
ACGCGTTGCCTGACTGCGTTAGCAATTTAACTGTGATAA

Pbla F
Pbla R

GCATCGTCGACTGAGACAATAACCCTGATAAATGCTTCAAT
GCATCACGCGTACTCTTCCTTTTTCAATATTATTGAAGCAT

PlacZ F
PlacZ R

GCATCCTGCAGCGCGTTGCGTTAATTACACT
GCATCACGCGTTCGACAAAGGACACACTTTA

GGTACCTCCATATTTATGCTGTTTCCGACCTGACACCTGCGTGAGTTGTTCACGTA

5. Klebsiella pneumoniae
pqq5 F
pqq5 R
pqq3 F
pqq3 R

GCATCGGATCCGTTATATTGTAAACATAAAGTTAA
GCATCGCTGCACCCATTTGCGCCGGGTCT
GCATCGTCGACCGGCAGATAACCCACTGGCTGCAG
GCATCGGATCCTTAATCCCCTGTCGTGAATAGCAC

6. I-SceI and araC-PBAD
I-SceI F
I-SceI R

GCATCAGAATTCATGCATCAAAAAAACCAGGTA
GCATCCTGCAGACTGCAGTTATTTCAGGAAAGT

araC-F
Pbad-R

GCATCAATCGATTAGGGATAACAGGGTAATAGAGTTTGTAGAAACGCAAAAAGG

GCATCATCGATTTATGACAACTTGACGGCTACATC

7. Antibiotic Markers
AMP F
AMP R

GCATCACGCGTCCAATGCTTAATCAGTGAGGCACC
GCATCGGTACCATGAGTATTCAACATTTCCGTGT
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KAN F
KAN R

GCATCACGCGTATGAGCCATATTCAACGGGAAACG
GCATCGGTACCTTAGAAAAACTCATCGAGCATCGA
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Appendix D: Recombination and Transformation Efficiencies.
Table 5. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

galK
beta-lactamase
Condition
1

3

4

5

6

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

Rec.

4.86
100

6.58
100

6.25
70

6.76
90

2.67
100

3.10
100

7.01
40

3.78
50

0.53
80

0.70
100

6.61
10

4.19
10

JM109(DE3)

Transf.
Rec.

6.49
100

8.65
100

7.97
70

6.99
80

2.27
100

2.92
100

6.52
40

4.67
40

0.47
100

0.87
90

6.68
20

6.11
10

XL1-Blue MRF'

Transf.
Rec.

9.20
100

9.83
100

1.67
100

2.77
100

7.50
40

7.07
50

0.67
90

1.00
100

6.33
10

6.23
20

BL21(DE3)pLysS Transf.

Strain

2

RecET

8.67
70

9.33
70

Transformation efficiency (Transf.) is measured by the number of colony forming units on LB plates containing Ampicillin (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome ((no. of positives / total
tested)*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 6. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

gntT
beta-lactamase
Condition

Strain

1

2

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

BL21(DE3)

Transf.
Rec.

2.77
90

5.97
100

6.38
70

6.42
80

2.73
100

3.33
100

6.85
50

6.91
60

0.27
100

0.60
100

6.27
10

6.16
10

JM109(DE3)

Transf.
Rec.

4.10
100

6.53
100

7.24
70

6.23
70

1.73
100

2.63
100

6.61
50

6.39
40

0.17
100

0.73
100

5.94
0

6.57
10

XL1-Blue MRF'

Transf.
Rec.

2.53
90

6.43
100

2.87
100

3.60
100

7.39
40

7.21
50

0.30
100

0.50
100

6.41
10

6.43
0

7.13
70

7.83
80

Transformation efficiency (Transf.) is measured by the number of colony forming units on LB plates containing Ampicillin (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome ((no. of positives / total tested)
*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 7. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

lac operon
beta-lactamase
Condition

Strain

1

2

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

BL21(DE3)

Transf.
Rec.

3.20
90

4.33
90

4.74
80

6.22
80

1.27
100

4.07
100

5.60
30

6.43
40

0.13
100

0.57
100

6.45
10

6.22
10

JM109(DE3)

Transf.
Rec.

1.07
100

3.30
90

4.67
70

5.88
80

1.37
100

3.77
90

7.51
40

4.82
30

0.27
100

0.33
100

5.73
20

6.57
10

XL1-Blue MRF'

Transf.
Rec.

1.60
100

5.17
100

2.07
100

3.20
100

3.67
40

7.73
50

0.43
100

0.17
100

5.78
10

8.21
10

6.32
90

7.67
70

Transformation efficiency (Transf.) is measured by the number of colony forming units on LB plates containing Ampicillin (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome ((no. of positives / total tested)
*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 8. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

galK
Kanamycin
Condition

Strain

1

2

RecET
2.70

Redαβ
4.10

100

100

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

3.07

5.85

100

100

XL1-Blue MRF'

Transf.
Rec.

1.67
100

3.47
100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

5.07
70

5.47
70

3.20
90

3.77
100

5.87
70

5.20
50

0.17
100

0.37
100

6.57
0

4.77
20

5.15
60

5.61
90

5.07
100

3.99
100

5.97
50

6.47
70

0.57
100

0.43
100

4.97
10

7.00
30

2.67
100

3.07
100

5.70
70

4.97
60

0.20
100

0.33
100

7.81
10

5.30
30

6.63
50

5.23
60

Transformation efficiency (Transf.) is measured by the number of colony forming units on MacConkey agar containing Kanamycin (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome((no. of positives / total tested)
*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 9. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

gntT
Kanamycin
Condition

Strain

1

2

RecET
2.80

Redαβ
3.20

100

100

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

4.67

5.50

100

90

XL1-Blue MRF'

Transf.
Rec.

3.40
100

3.97
100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

1.80
90

2.03
80

2.70
100

3.33
100

4.93
50

4.30
70

0.13
100

0.33
90

5.37
0

5.37
10

3.37
60

4.40
70

3.37
100

4.00
100

5.60
60

6.47
30

0.13
100

0.23
100

6.10
0

4.33
0

1.87
100

2.77
100

6.50
30

4.10
60

0.17
100

0.20
100

6.70
10

4.60
10

1.23
70

1.43
80

Transformation efficiency (Transf.) is measured by the number of colony forming units on MacConkey agar containing Kanamycin (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome((no. of positives / total tested)
*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 10. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

lac operon
Kanamycin
Condition

Strain

1

2

RecET
3.87

Redαβ
4.27

100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

100

3.77
50

5.03
60

3.93
100

4.53
100

6.37
50

6.77
70

0.13
100

0.10
100

3.90
10

4.87
10

4.13
30

5.23
60

2.93
100

3.87
100

7.17
40

7.43
70

0.10
100

0.33
100

4.37
10

5.03
0

1.83
100

2.83
100

0.43
30

0.80
60

0.07
90

0.10
100

6.17
10

5.73
20

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

4.50
100

4.93
100

XL1-Blue MRF'

Transf.
Rec.

3.27
100

3.57
100

4.27
20

3.67
40

Transformation efficiency (Transf.) is measured by the number of colony forming units on MacConkey agar containing Kanamycin (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome ((no. of positives / total tested)
*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 11. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

galK
pqq operon
Conditions

Strain

1

2

RecET
6.07

Redαβ
5.90

100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

100

7.60
50

5.27
70

4.87
100

5.73
100

4.60
30

5.47
40

0.13
100

0.33
100

4.97
25

5.80
33

5.40
50

6.10
60

4.63
100

5.83
100

5.57
30

3.27
30

0.10
100

0.27
100

5.87
10

5.53
11

3.23
100

4.77
100

5.93
20

6.73
40

0.07
100

0.17
100

6.80
29

5.50
10

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

6.43
100

6.80
100

XL1-Blue MRF'

Transf.
Rec.

7.00
90

4.20
100

6.87
50

7.47
50

Transformation efficiency (Transf.) is measured by the number of PQQ-positive colonies divided by the total number of colony forming units on
LB agar (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) in colonise that are PQQ- positive ((no. of positives /
total tested)*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.

105

Table 12. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

gntT
pqq operon
Condition

Strain

1

2

RecET
3.37

Redαβ
5.60

100

3

4

5

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

100

6.47
40

5.60
60

5.30
100

6.13
100

6.43
60

6.83
70

6.17
30

4.73
40

3.27
100

4.63
100

4.43
30

3.17
100

2.93
100

5.90
20

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

2.10
100

3.63
100

XL1-Blue MRF'

Transf.
Rec.

2.47
100

3.83
100

5.20
30

6.27
30

6

RecET
0.10

Redαβ
0.17

RecET

Redαβ

100

5.57
10

5.77
20

100

5.73
50

0.20
100

0.17
100

5.63
0

5.40
20

7.10
40

0.20
100

0.27
100

6.47
30

6.00
10

Transformation efficiency (Transf.) is measured by the number of PQQ-positive colonies divided by the total number of colony forming units on
LB agar (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) in colonise that are PQQ-positive ((no. of positives /
total tested)*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 13. Transformation and recombination efficiencies under various transformation conditions.
Target:
Insert:

lac operon
pqq operon
Condition

Strain

1

2

RecET
4.23

Redαβ
6.70

100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

100

7.17
30

5.23
30

1.27
100

1.67
100

5.30
30

5.53
40

0.47
100

0.60
100

3.37
0

4.60
10

4.57
40

6.43
30

1.20
100

2.83
100

6.93
20

6.10
60

0.33
100

0.43
100

5.60
0

4.00
30

0.97
100

2.77
100

7.43
30

6.80
30

0.20
100

0.23
100

6.00
20

6.87
20

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

2.77
100

7.07
100

XL1-Blue MRF'

Transf.
Rec.

3.20
100

6.07
100

7.20
20

6.80
20

Redαβ

Transformation efficiency (Transf.) is measured by the number of PQQ-positive colonies divided by the total number of colony forming units on
LB agar (x10E7).
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) in colonise that are PQQ-positive ((no. of positives /
total tested)*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 14. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

galK
gadh operon
Condition

Strain

1

2

RecET
5.67

Redαβ
5.47

100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

100

5.30
20

4.97
50

6.77
100

5.07
100

4.47
50

3.50
70

0.67
100

0.43
100

5.07
10

5.33
20

2.97
30

5.47
60

3.60
100

5.13
100

6.47
40

5.63
60

0.27
100

0.83
100

5.67
20

4.87
20

4.87
100

6.20
100

5.83
40

6.27
50

0.20
100

0.33
100

6.57
10

5.17
20

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

5.40
100

5.53
100

XL1-Blue MRF'

Transf.
Rec.

6.27
100

6.03
100

4.90
50

2.83
50

Transformation efficiency (Transf.) is measured by the number of gadh positive colony forming units on LB agar.
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome ((no. of positives / total tested)
*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 15. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

gntT
gadh operon
Condition

Strain

1

2

RecET
2.50

Redαβ
7.20

100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

100

6.20
50

5.30
60

2.07
100

3.10
100

3.67
40

4.03
60

0.33
100

0.40
100

5.70
10

5.13
20

6.83
40

5.37
40

1.97
100

2.73
90

6.90
30

4.43
70

0.20
100

0.43
100

6.17
0

5.93
10

1.57
100

3.27
100

5.17
50

3.87
50

0.30
100

0.57
90

5.43
10

7.47
10

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

2.93
100

4.30
100

XL1-Blue MRF'

Transf.
Rec.

1.37
100

3.70
100

7.73
30

6.50
60

Transformation efficiency (Transf.) is measured by the number of gadh positive colony forming units on LB agar.
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome ((no. of positives / total tested)*
100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.
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Table 16. Transformation and Recombination Efficiencies under varying Transformation Conditions.
Target:
Insert:

lac operon
gadh operon
Conditions

Strain

1

2

RecET
2.70

Redαβ
3.30

100

3

4

5

6

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

RecET

Redαβ

100

4.47
20

5.90
60

0.67
100

0.97
100

3.97
40

2.90
40

0.50
100

0.77
100

4.80
10

5.40
10

6.70
20

5.63
50

1.23
90

2.80
100

6.57
40

5.67
30

0.37
100

0.73
100

7.43
10

6.57
14

0.77
100

1.83
100

6.20
50

7.27
20

0.27
100

0.87
100

7.13
13

7.40
22

BL21(DE3)

Transf.
Rec.

JM109(DE3)

Transf.
Rec.

2.23
100

3.53
100

XL1-Blue MRF'

Transf.
Rec.

0.90
100

1.50
100

7.43
30

7.80
40

Transformation efficiency (Transf.) is measured by the number of gadh positive colony forming units on LB agar.
Recombination efficiency (Rec.) is measured by PCR detection of the inserted gene(s) on the E. coli genome ((no. of positives/total tested)
*100).
1.
2.
3.
4.
5.
6.

Pre-transformed with both vectors, then a linear insert cassette.
Pre-transformed with both vectors containing an integrated insert cassette.
Pre-transformed with pBS-derived, then pACYC-derived vector (linear insertion cassette).
Pre-transformed with pBS-derived vector containing an integrated insertion cassette, then pACYC-derived vector.
Pre-transformed with pACYC-derived vector, then pBS-derived plus a linear insert.
Pre-transformed with pACYC-derived vector, then pBS-derived plus integrated insert.

110

Appendix E: Experimental Protocols.
A. Plasmid DNA Isolation (1)
The following protocol was taken from Sigma’s GenEluteTM Plasmid Miniprep Kit
and was one of two methods used in the isolation of plasmid DNA.

1. Transfer 300 µl (1 ml if low-copy) of recombinant E. coli to a microfuge tube
and pellet cells at ≥12,000 x g for 1 minute. Discard the supernatant.
2. Lyse the resuspended cells by adding 200 µl of the Lysis Solution.
Immediately mix the contents by gentle inversion (6-8 times) until the mixture
becomes clear and viscous. Do not allow the lysis reaction to exceed 5
minutes.
3. Precipitate the cell debris by adding 350 µl of the Neutralization/Binding
Solution.

Gently invert the tube 4-6 times. Pellet the cell debris by

centrifuging at ≥12,000 x g or maximum speed for 10 minutes.
4. Insert a GenElute Miniprep Binding Column (with a blue o-ring) into a
provided microfuge tube. Add 500 µl of the Column Preparation Solution to
each miniprep column and centrifuge at 12,000 x g for 30 seconds to 1
minute. Discard the flow through liquid.
5. Transfer the cleared lysate from step 3 to the column prepared in step 4 and
centrifuge at ≥12,000 x g for 30 seconds to 1 minute. Discard the flow-through
liquid.
6. Add 500 µl of the Optional Wash Solution to the column. Centrifuge at
≥12,000 x g for 30 seconds to 1 minute. Discard the flow-through liquid.
7. Add 750 µl of the diluted Wash Solution to the column. Centrifuge at ≥12,000
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x g for 30 seconds to 1 minute. Discard the flow-through liquid and centrifuge
again at maximum speed for 1 to 2 minutes without any additional Wash
Solution to remove excess ethanol.
8. Transfer the column to a fresh collection tube. Add 75 µl of nuclease-free
water to the column. Centrifuge at ≥12,000 x g for 1 minute. The DNA is now
present in the eluate and is ready for immediate use or storage at –20 °C.
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B. Plasmid DNA Isolation (2)
The following protocol was taken from Zymo Research’s Zyppy Plasmid Miniprep
Kit and was one of two methods used in the isolation of plasmid DNA.

1. Pellet 700µl of overnight culture (1.5 ml if low-copy) in a 1.5 ml microfuge tube
by spinning at full speed for 15-20 seconds.
2. Discard supernatant as much as possible.
3. Add 200 µL of buffer P1 and resuspend pellet completely.
4. Add 200 µL of buffer P2 and mix by inverting and swirling the microfuge tube
for 4 - 6 times.
5. Add 400 µL of buffer P3 and mix thoroughly, but gently. Do not hard vortex.
6. Spin for 3 minutes.
7. Load the supernatant to the Zymo-spin III column.
8. Spin the Zymo-spin column with the collection tube for 30 seconds.
9. Discard the flow-through in the collection tube.
10. Add 600 µL of Wash Buffer onto the column with the collection tube and spin
for 30 seconds.
11. Add 40 µL of nuclease-free water to the column and place the column onto a
1.5 ml microfuge tube, spin for 10-15 seconds to elute the plasmid.
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C. Isolation of Genomic DNA
The following protocol was adapted from Sigma’s GenEluteTM Bacterial Genomic
DNA Kit which was used to isolate all genomic DNA.

1. Pellet 750 µl of an overnight bacterial broth culture by centrifuging for 2
minutes at 12,000-16,000 x g. Remove the culture medium completely and
discard.
2. Resuspend the pellet thoroughly in 180 µl of Lysis Solution T.
3. Add 20 µl of the Proteinase K solution to the sample. Mix and incubate for 60
minutes at 55 °C.
4. Add 200 µl of Lysis Solution C, vortex thoroughly (about 15 seconds), and
incubate at 55 °C for 30 minutes.
5. Add 500 µl of the Column Preparation Solution to each pre-assembled
GenElute Miniprep Binding Column seated in a 2 ml collection tube.
Centrifuge at 12,000 x g for 1 minute. Discard the flow-through liquid.
6. Add 200 µl of ethanol (95-100%) to the lysate and mix thoroughly by vortexing
for 5-10 seconds. A homogeneous mixture is essential.
7. Transfer the entire contents of the tube into the binding column. Use a wide
bore pipette tip to reduce shearing the DNA when transferring the contents
into the column. Centrifuge at ≥6500 x g for 1 minute. Discard the collection
tube containing the flow-through liquid and place the column in a new 2 ml
collection tube.
8.

Add 500 µl of Wash Solution O to the column and centrifuge for 1 minute at
≥6,500 x g. Discard the collection tube containing the flow-through liquid and
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place the column in a new 2 ml collection tube.
9.

Prior to first use, prepare the Wash Solution by diluting the Wash Solution
Concentrate with ethanol as described under Preparation Instructions. Add
500 µl of Wash Solution to the column and centrifuge for 3 minutes at
maximum speed (12,000-16,000 x g) to dry the column. The column must be
free of ethanol before eluting the DNA. Centrifuge the column for an
additional 1 minute at maximum speed if residual ethanol is seen. Finally,
discard the collection tube containing the flow-through liquid and place the
column in a new 2 ml collection tube.

10. Pipette 200 µl of the nuclease-free directly onto the center of the column;
centrifuge for 1 minute at ≥6,500 x g to elute the DNA. To increase the elution
efficiency, incubate for 5 minutes at room temperature after adding the
nuclease-free water, then centrifuge. Repeat with an additional 200 µl of
nuclease-free water.
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D. DNA clean up from enzymatic reactions
Enzymatically-manipulated DNA was cleaned using the DNA Clean and
Concentrator Kit from Zymo Research.

1. Add 2 volumes of DNA Binding Buffer to each volume of DNA sample.
2. Load sample into a Mini-Spin Column and place column into a 2 ml collection
tube.
3. Centrifuge at ≥10,000 g for 5-10 seconds. Discard the flow-through.
4. Add 200 µl of Wash Buffer to the column. Spin at ≥10,000 g for 5-10 seconds.
Add an additional 200 µl of Wash Buffer. Spin at ≥10,000 g for 30 seconds.
5. Add 35 µl of nuclease-free water directly to the column matrix. Place column
into a 1.5 ml tube. Spin 60 seconds at ≥10,000 g to elute DNA.
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E. DNA Extraction from agarose
All DNA fragments were isolated using Zymoclean Gel DNA Recovery Kit from
Zymo research.

1. Excise the DNA fragment from the agarose gel with a razor blade and transfer
to a 1.5 ml tube.
2. Add 3 volumes of Agarose Dissolving Buffer to each volume of agarose gel.
3. Incubate at 55°C for 5-10 minutes to dissolve gel completely.
4. Load the melted agarose solution into a Zymo-Spin Column and place column
into a 2 ml collection tube.
5. Centrifuge at ≥10,000 g for 5-10 seconds. Discard the flow-through.
6. Add 200 µl of Wash Buffer to the column. Spin at ≥10,000 g for 5-10 seconds.
Add another 200 µl of Wash Buffer. Spin at ≥10,000 g for 30 seconds.
7. Add 6-8 µl of nuclease-free water directly to the column matrix. Place column
into a 1.5 ml tube. Spin 60 seconds at ≥10,000 g to elute DNA.
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F. Isolating the GADH operon from Pseudomonas aeruginosa

1. Partially Kpn I digest to PAO1 genomic DNA. Use the serial dilution method
and incubate at 37°C for 15 minutes.
2. Separate the Kpn I fragments on a 1% TAE-agarose gel, 2 hours at 65 volts.
3. Isolate the 5 to 6 kilobase fragments.
4. Ligate the PAO1 fragments to Kpn I, SAP-treated pBluescript.
5. Transform E. coli (XL1-Blue MRF΄, DH5α or TOP 10F-). Plate on LB or SOB
plates that contain 100 µg/ml ampicillin and 50 mM sodium gluconate.
6. Screen by soaking filter paper with the gluconate dehydrogenase assay
solution and placing the filter over the colonies.

Transfer colonies that

undergo an immediate color change to 3 ml SOB media containing 100 µg/ml
ampicillin and 50 mM sodium gluconate. Incubate at 37°C overnight with
shaking at ~250 rpm.
7. Pellet cells and resuspend in 50 mM Tris-HCl, pH 7.5 containing 250 mM
sodium gluconate. Centrifuge the tubes at 7500 x g for 5 minutes at room
temperature.
8. Decant and resuspend in 3 ml of the same buffer and repeat the
centrifugation.

Decant and resuspend in 3 ml 50 mM Tris-HCl, pH 7.5

containing 250 mM sodium gluconate.
9. To the resuspended cells add 100 µl of DCIP and 50 µl of PMS. Positive
cells will undergo a color change from blue to yellow within 2 minutes.
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10. Transfer 2 ml of the positive cell solutions to 15 ml of liquid media containing
100 µg/ml ampicillin and 50 mM sodium gluconate. Incubate at 37°C for 3
hours while shaking at ~250 rpm.
11. Isolate plasmids from each positive cell flask, Kpn I digest and repeat
electrophoresis. Isolate the 4700 base pair band and ligate to Kpn I-digested,
SAP-treated pBluescript.
12. Transform E. coli and assay for GADH activity. Isolate the positives and reexamine the plasmids on a 1.0% gel. Repeat steps 6-12 until extraneous
bands are no longer present.
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G. Isolating the PQQ operon from Klebsiella pneumoniae

1. Completely digest K. pneumoniae genomic DNA with Xba I and Kpn I.
2. Separate DNA fragments using 1.0% TAE-agarose, 2 hours at 65 volts.
3. Excise and extract DNA in the 8-9 kilobase range.
4. Ligate Kpn I/Xba I fragments to Kpn I/Xba I, SAP-treated pBluescript.
5. Transform E. coli (XL1-Blue MRF’, DH5α or TOP 10F-) and plate on LB + SGal. Incubate overnight at 37°C.
6. Transfer all white colonies to 2 ml SOB media containing X-gal and IPTG.
7. Isolate plasmid DNA from all positive tubes and digest with Kpn I/Xba I.
8. Electrophorese using 1.0% TAE-agarose, 2 hours at 65 volts and excise
band(s) corresponding to 8.3 kilobases.
9. Repeat steps 4-8 until all extraneous bands are removed.
10. Xho I-digest the 8.3 kilobase fragment and electrophorese using 1.0% TAEagarose, 1.25 hours at 65 volts. The presence of 4.0 and 4.3 kilobase bands
indicates the presence of the PQQ operon.
11. Transform E. coli JM1109 (pts-) with all potential PQQ-containing plasmids
and plate on minimal media containing glucose.
12. Any colonies that form will possess the pqq operon.
13. Confirm by electrophoresis.
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H. Induction of the Targeted Recombination Vectors
Listed by experimental condition (see Tables 2-13).

1. Experimental conditions where a linear targeting cassette is employed.
a. Pre-transform with pBS and pACYC-derived vectors (Use recE/T or
exo/bet).
b. Plate on LB-agar 75 µg/ml Ampicillin and 30 µg/ml Chloramphenicol and
incubate overnight at 37°C.
c. Select several colonies and prepare as competent cells.
d. Transform using 0.3 µg of linear targeting cassette.
i. Incubate for 60 min in SOB media, plus arabinose.
e. Plate on appropriate agar media.
f. Screen for phenotype.

2. Experimental conditions where an integrated targeting cassette is employed.
a. Pre-transform with pACYC and pBS-derived vectors (integrated targeting
cassette).
i. Incubate for 60 min in SOB media, plus arabinose.
b. Plate on appropriate agar media.
c. Screen for phenotype.
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I. PCR-Detection of inserted DNA Fragments
All PCR reactions were carried out at 50 µl using either Hot Master Mix
(Eppendorf) or REDTaq Readymix Plus (Sigma Aldrich) under standard
conditions as described by the manufacturer.

Conditions were optimized for

each target in each E. coli strain for each insert.
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J. Gluconate Dehydrogenase Assay
1. Centrifuge 1 ml of bacteria grown overnight at 37°C in complete media
containing 20 mM gluconate, 15,000 x g, room temperature, 1 minute.
2. Resuspend in 1 ml Tris-HCl, 20 mM gluconate, pH 7.6
3. Repeat centrifuge.
4. Resuspend in 1 ml Tris-HCl, pH 7.6.
5. Add assay solution minus substrate (gluconate or glucose)* and transfer to
cuvette. Place in UV/Visible spectrometer at wavelength = 600 nm.
6. Add substrate (total volume equal to 3 ml).
7. Incubate 1 minute.
8. Record reading.

Assay Solution:
Component
DCIP
PMS
Substrate*

Final Volume
0.33 mM
0.1 mM
33.33 mM

Bring to a final volume of 3 ml using 20 mM Tris-HCl, pH 7.6

*Use gluconate for gluconate dehydrogenase and glucose for gluconate
dehydrogenase plus pyrroloquinoline quinone.
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K. Preparing Competent E. coli
Taken from Inoue, H., H. Nojima, and H. Okayama. (1990) High efficiency
transformation of Escherichia coli with plasmids. Gene 96:23-28.

1. Inoculate from an overnight grown in LB.
2. Grow in 250 ml SOB at 18C until OD600 = 0.6.
3. On ice for 10 minutes.
4. Spin at 2500 x g (5000 rpm in a Sorvall GSA) for 10 min. at 4C.
5. Resuspend cells gently in 80 ml of ice cold TB
6. Incubate on ice for 10 minutes.
7. Spin at 2500 x g (5000 rpm in a Sorvall GSA, 5500 rpm in a Sorvall SS-34)
for 10 min. at 4C.
8. Resuspend cells gently in 20 ml of ice cold TB.
9. Add DMSO to a final concentration of 7%.
10. Place on ice for 10 minutes.
11. Aliquot into 1-2 ml and freeze in liquid nitrogen.
12. Store in liquid nitrogen.
Transformation Buffer = 55 mM MnCl2, 15 mM CaCl2, 250 mM KCl. Adjust pH to
6.7 with 5N KOH prior to adding the MnCl2.
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L. Transformation of E. coli

1.

Add 0.3 µg of DNA (volume no greater than 20 µl) to 50 µl of frozen,
competent cells.

2.

Incubate on ice for 30 minutes.

3.

Heat shock at 42°C for the appropriate amount of time for the particular
strain of bacteria.

4.

Add 200 µl of SOB media containing 100 µM arabinose and incubate at
37°C for 45 minutes.

5.

Transfer to agar plate with appropriate antibiotic.

6.

Incubate overnight at 37°C.
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